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Chapter I. 
Introduction 
1 .I. Osteoporosis as a public health problem 
The investigation that is the subject of this thesis intended to evaluate the 
clinical value of risk factors of osteoporosis for prediction of fractures. 
Osteoporosis and related fractures constitute a frequently occurring and 
expanding medical problem in the elderly population. The occuiTence of skeletal 
fractures is approximately five times more frequent in women aged 85 years as 
compared to women aged 45 years. 1 Osteoporosis. a condition characterised by a 
reduced amount of bone tissue in the skeleton. may be a major cause of the 
age related increase in fracture risk. 
Although osteoporosis is by no means a new disease. it has become a signifi-
cant public health problem only recently. In the past decade, the absolute 
number of elderly fracture patients has grown considerably. In I 972 approxi-
mately 6000 subjects aged 65 years and over were admitted to Dutch hospitals 
for treatment of a limb fracture. Ten years later, in 1982 the number of 
hospital treated fracture patients of this age had increased by 65 per cent. to 
more than 10.000 patients.2 These figures represent only a small fraction of all 
fracture patients. since the majority of fractures will have been treated in out-
patient facilities. The rise in the absolute number of fractures may be explained 
from two factors. Firstly. there has been some increase in the age specific 
incidence of (hip) fractures. 3 Secondly. the size of the population with a high 
risk of fractures. has grown considerably. Between I 972 and 1982. the size of 
the Dutch population of subjects aged 65 years and over increased by 20 per 
cent: the population aged 75 years and over increased by 35 per cent: and the 
female population aged 75 years and over increased by more than 45 per cent. 
In the latter group the risk of fractures is particularly high.4 ·5 For the future 
it is expected that the absolute number of elderly subjects will continue to 
increase. 6 As a consequence the "epidemic" of fractures among the elderly will 
fwiher expand. The financial consequences of the large number of fractures 
may be considerable. For the USA. the financial costs of osteoporosis has been 
I I 
estimated at 6. I billion dollar in 1983. 7 
In the past few years osteoporosis has become a major health issue for the 
general public. The condition has been frequently discussed: both m the 
professional and in the lay press. News papers and popular magazines have 
regularly devoted their pages to inform the public about the disease. For the 
same reason several popular books have been published. some of which had 
provoking titles such as: "Osteoporosis: your head start on the prevention and 
treatment of brittle bones". 8 All this publicity may add to the impression of an 
epidemic disease threatening the integrity of our bones. 
1.2. Aim and background of the investigation 
The medical professional interest in the subject of osteoporosis has been 
remarkably high. In the three years between 1984 and 1987. at least three 
consensus conferences have been organised on the subject. 9 ·1 0· 11 This high 
consensus activity may be a reflection of the increasing magnitude of the 
problem. It may also reflect the ditiiculty among expet1s in the field of osteo-
porosis. to agree on matters of substantial importance. The experts do agree 
about the impot1ance of osteoporosis prevention. The process of bone loss 
proceeds only slowly. but it may continue over a long period of time. In clue 
time. thirty per cent or more of an individual's total amount of bone tissue may 
be lost. This will result in a significant reduction in the mechanical strength of 
the skeleton. Once the bone loss has occurred. little or nothing can be done to 
restore the initial skeletal mass. Therefore. it makes sense. to start with 
prevention of bone loss long before osteoporosis manifests itself in the form of 
fractures. 
For postmenopausal women. who are the major risk group. oestrogen substi-
tution therapy is accepted by the majority of experts as the most promising 
intervention strategy in this respect. It has been suggested that women with a 
high risk of developing osteoporosis could be treated prophylactically vvith this 
kind of therapy. shortly after menopause. There is very little agreement. 
however. among the experts about the identification of a high risk group. 12 One 
approach that has been suggested for this purpose is the use of the risk factor 
12 
status. 13 In the medical literature many risk factors of osteoporosis have been 
described. For example. factors such as low body mass. early menopause. a diet 
low in calcium and lack of physical exercise have all been related to osteopo-
rosis. It has been suggested that individuals with many risk factors should be 
selected for fracture prevention programmes. The study described in this thesis 
was designed to test the validity of this concept. In a longitudinal population 
based investigation among 1167 women initially aged 45 to 64 years. baseline 
risk factor status was related to the occuJTence of fractures during a nine year 
follow-up period. The simultaneous influence on fracture risk of a combination 
of risk factors was expressed for each individual in a Fracture Risk Score. 
indicating the personal risk of fractures. 
Next to the main question concerning fracture prediction. two additional 
questions were addressed. Firstly. the existence of differences in the rate of 
bone loss between individuals was evaluated longitudinally. From cross-sectional 
investigations it has been inferred that bone loss is a frequently occurring 
phenomenon in postmenopausal women as a group. Longitudinal data concerning 
the rate of bone loss may be helpful to further define a population at risk for 
osteoporosis. Secondly. the role of endogenous oestrogen activity was evaluated 
as a potential contributing factor in the etiology of osteoporosis. 
1.3. The structure of the thesis 
In chapter two a selective review of the literature is presented. The develop-
ment of the concept of osteoporosis is described in a historical perspective. and 
the literature concerning the epidemiology of osteoporosis is described. In 
chapter three. the study population and methodology are described. In the 
chapters four to six the results of the investigation are presented. Chapter four 
deals with prediction of fractures: chapter five with differences in the rate of 
bone loss: and chapter six with the role of endogenous oestrogen activity as a 
potential cause of postmenopausal osteoporosis. ln chapter seven the results of 
the investigation are discussed and some recommendations are made for preven-
tion of osteoporosis and for further epidemiological research. 
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Chapter 2. 
Osteoporosis since Albright 
2.1. Introduction 
In this review of the literature the development of the concept of osteo-
porosis is described in a historical perspective. A distinction is made between 
osteoporosis as a clinical syndrome and osteoporosis as a phenomenon in the 
general population. This distinction was thought to be useful. because the 
manifestation of osteoporosis may appear different in clinical observations of 
individual patients or in epidemiological observations of the general population. 
The epidemiological view. being the subject of this thesis. will be discussed in 
further detail. The clinical and epidemiological literature on osteoporosis has 
been recently reviewed by Thomson. 1 Cummings.2 and Riggs.3 
2.2. The concept of osteoporosis 
Osteoporosis can be considered as a condition in which the amount of bone 
tissue in the skeleton is reduced to an extent that fractures can easily occur.4 
The osteoporotic condition may occur in relation to a multitude of diseases and 
syndromes that are known to influence bone metabolism. A classification of 
osteoporosis is presented in Table I. Osteoporosis occurs most frequently as a 
primary condition among women in the menopause or among men and women at 
old age (i.e. postmenopausal or senile osteoporosis). In women. the distinction 
between the two conditions is often vague. Idiopathic osteoporosis -which is a 
f01m of osteoporosis of unknown etiology that occurs in young or middle aged 
subjects- and osteoporosis as a secondary condition are both relatively rare. 
Skeletal wasting is held responsible for many of the fractures that occur in 
elderly people. Although the condition has been recognized as a clinical 
syndrome comparatively recently. it has probably existed for at least 3000 years. 
Perzigian described reduced amounts of bone tissue in the skeletons of the 
elderly members of an indian population. who lived between 2500 and 2000 BC 
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Table I A classificatiOii of osteoporosis. 4 
I. Common forms of osteoporosis of unknown cause not associated with other 
disease. 
A. Idiopathic osteoporosis (juvenile and adult) 
B. Postmenopausal osteoporosis 
C. Senile osteoporosis 
II. Disorders or conditions in which osteoporosis is a common feature or 
pathogenesis partially understood. 
A. Hypogonadism 
B. Hyperadrenocorticism 
C. Thyrotoxicosis 
D. Malabsorption 
E. Scurvy 
F. Calcium deficiency 
G. Immobilization 
H. Chronic heparin administration 
I. Systematic mastocytosis 
J. Adult hypophosphatasia 
K. Associated with other metabolic bone disease 
Ill. Osteoporosis as a feature of heritable disorders of connective tissue. 
A. Osteogenesis lmperfecta 
B. Homocystinuria due to cystathionine synthase deficiency 
C. Ehlers-Danlos syndrome 
D. Mmfan syndrome 
IV. Disorders in which osteoporosis is associated but pathogenesis not under-
stood. 
A. Rheumatoid a11h1itis 
B. Malnutrition 
C. Alcoholism 
D. Epilepsy 
E. Diabetes 
F. Chronic obstructive pulmonary disease 
G. Menke"s syndrome 
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on the northeastern bank of the Green river m Ohio. Kentucky.5 
Early clinical descriptions of bone wasting have been given by several authors 
in the 19th century.6 "7 Sir Astley Cooper. for example. observed in 1824 that in 
old age bones "become thin in their shell and spongy in their texture". On an 
autopsy. on a lady who had suffered a hip fracture. William Porter noted in 
I 836 that "The entire osseous system was weak and fragile: the fibula gave way 
under the pressure of the finger and thumb and was crushed as easily as an egg 
shell". 
The first formal description of osteoporosis has been ascribed to Pommer. 8 In 
1885. this german pathologist published a monograph on osteomalacia. in which 
he suggested a classification of those diseases of the skeleton that were 
characterised by a reduced calcium content of the bone. On the basis of 
histological criteria he proposed a division in three categories: osteomalacia. 
osteitis fibrosa (abnmmality of the bone tissue in hyperparathyroidism) and 
osteoporosis. Incomplete mineralisation of the bone matrix was described as the 
charactetistic feature in osteomalacia. In osteitis fibrosa normal bone tissue was 
replaced by fibrous tissue and in osteoporosis the bone tissue was considered to 
be histologically nmmal. The reduced amount of bone tissue was described as 
the sole abnmmality in osteoporosis. 
2.2.1. Albright: osteoporosis as a disease 
Osteoporosis was not recognized as a disrinct disorder in medical practice 
until Fuller Albright drew attention to the condition around 1940.9 "10 "11 Before 
Albright, the diagnosis osteoporosis was commonly confused with osteomalacia. 
Albright again made a distinction between osteoporosis. osteomalacia and osteitis 
fibrosa. He suggested basic metabolic differences between these conditions. with 
implications for simple clinical diagnostic criteria to discriminate one condition 
from the other. Furthermore. he proposed a multitude of hypotheses concerning 
the etiology and pathogenesis of osteoporosis. He described many case histories 
to illustrate his theories. At the same time these histmies served as a clinical 
description of the condition. Finally. Albright introduced the use of oestrogens 
as a therapy for the newly discovered syndrome. By and large. the work of 
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Albright changed the theoretical concept of osteoporosis as described by 
Pommer into a clinical reality. 
In the conception of Albright. osteoporosis was a disease of the bone tissue 
that was characterised by a deficient amount of bone in the skeleton. because 
of a defective bone formation. A clinical diagnostic differentiation between 
osteoporosis. osteomalacia and osteitis fibrosa was suggested on the basis of 
serum phosphatase. urinary calcium and urinary phosphorous concentrations. 
These were essentially normal in osteoporosis. 
Concerning the etiology of osteoporosis Albright considered a multitude of 
factors. including the postmenopausal state. disuse. dietary deficiency. gastlic 
hypoacidity. repeated pregnancies. longstanding thyrotoxicosis. senescence. 
Cushing's disease and acromegaly. He considered postmenopausal and senile 
osteoporosis as the two most frequent manifestations of the syndrome. The 
importance of the postmenopausal state as an etiological factor was illustrated 
in a paper in 194 I. in which Albright described all known cases of generalised 
osteoporosis -without an obvious cause. like infantile paralysis- that could be 
traced since I 931 in subjects aged less then 65 years. Of 42 cases. 40 were 
women who had passed the menopause. The patients were invariably charac-
terised by an increased radiotranslucency of the spine and sometimes by an 
increased translucency of other bones as well. Eighty per cent of the patients 
had suffered from spinal fractures: five per cent of other fractures and ten per 
cent had suffered from pain but had no fractures. The remaining five per cent 
of the patients had an increased skeletal radiotranslucency as the only symptom. 
The manifestation of osteoporosis as a disease that is characterised by a 
reduced amount of bone tissue. especially in the axial skeleton. accompanied by 
the occurrence of vertebral fractures and perhaps back pain still dominates the 
clinical conception of osteoporosis. 4 
2.2.2. Newton-John: osteoporosis as a general phenomenon in man 
After osteoporosis had become established as a disease of clinical relevance. 
research activity became clirectecl towards the further exploration of its 
manifestations. Radiological techniques were developed for in-vivo measurement 
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of the amount of bone tissue in the skeleton. Bone density was quantified both 
in normal and in supposedly osteoporotic populations. The accumulated data 
concerning the relationship between ageing. bone loss and fractures was 
reviewed in 1970 by Newton-John and Morgan. 12 In this review. the concept of 
osteoporosis as a disease was seriously challenged. An analysis of the available 
data from 30 unnamed publications concerning the amount of bone tissue in 
relation to age and sex led Newton-John and Morgan to the following 
conclusions: 
" I. All persons lose bone with age. 
2. There is so far no evidence that osteoporosis in the older population is the 
result of either an excessive rate of loss or an abnormal total loss of bone. 
3. The risk of fractures is largely determined by the amount of bone. and the 
increase in frequency of fracture with age is largely determined by the 
normal loss of bone with age." 
According to this epidemiological view of osteoporosis. the existence of a 
subgroup of the population suffering from a disease called osteoporosis was 
denied. The argumentation was mainly built on the observations of many cross-
sectional population based studies. in which -despite a continuous decline of 
bone density in elderly subjects- the range in the values of bone density 
(standard deviation) remained constant. The lack of an increasing trend in the 
standard deviation of bone density between consecutive age groups was inter-
preted as an argument for the homogeneity of the process of bone loss within 
the population. The age related increase in fracture incidence was explained 
from an increase in the number of individuals with a low bone density. Low 
bone density was considered as a risk factor for all fractures: not just vertebral 
fractures. It was argued that. as a result of the normal bone loss that occurs at 
a similar (physiological) rate in all old people. the prevalence of this risk factor 
does increase as the population grows older. and so does the total fracture 
incidence. 
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2.2.3. Riggs: back to Albright ? 
In the past decade. the techniques for measuring the amount of bone tissue. 
particularly of the axial skeleton. have improved and an increasing amount of 
data on fracture incidence has become available. On the basis of the recent 
literature. Riggs and Melton m have suggested a solution for the controversy 
between Albright and Newton-John. by postulating the existence of two distinct 
syndromes of involutional osteoporosis. 13 Firstly. a syndrome that they labeled 
Type I osteoporosis. which occurs in a relatively small subset of postmenopausal 
women who are 5 I to 65 years of age. Secondly. Type II osteoporosis. which 
occurs in a large proportion of women or men who are older than 75 years. 
Type I osteoporosis was formerly known as postmenopausal osteoporosis. It is 
characterised by an accelerated and disproportionate loss of trabecular bone. 
Fractures of the vertebral bodies and of the forearm are the typical fractures 
for this type of osteoporosis. These skeletal sites contain predominantly 
trabecular bone. Oestrogen deficiency has been implicated as an etiologic agent. 
but other factors have been suggested as well. This syndrome corresponds to 
the clinical description of osteoporosis according to Albright. 
Type II osteoporosis was formerly known as senile osteoporosis. It is charac-
terised by a proportionate loss of both cortical and trabecular bone and the 
rate of bone loss is similar to that of the general population. Fractures of the 
hip. proximal humerus, proximal tibia and pelvis are the typical fractures. These 
sites of the skeleton contain substantial amounts of both cortical and trabecular 
bone. Impaired bone formation and secondary hyperparathyroidism have been 
implicated as etiologic factors. The syndrome corresponds to the Newton-John 
and Morgan concept of bone loss. 
At present. the available data on age related changes in axial bone density 
are still relatively scarce. and it is too early for an evaluation of the clinical 
value of the distinction between type I and type II osteoporosis. 
In summary. Pommer first described a theoretical concept of osteoporosis in 
1885. Albright defined the clinical syndrome in I 940. and among others. he made 
a distinction between postmenopausal and senile osteoporosis. In I 970. the 
concept of osteoporosis as a disease was challenged by Newton-John and 
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Morgan. who suggested that -after a certain age- bone loss had to be consi-
dered as a physiological process. In 1983. Riggs presented a "new" model of 
type I and type II osteoporosis. which closely resembled the former distinction 
between postmenopausal and senile osteoporosis. The value of this distinction 
remains to be established. 
2.3. Epidemiology of osteoporosis 
In the following paragraphs a selection of the literature concerning the 
epidemiology of bone loss and fractures is presented. and the relationship 
between bone density and the risk of fractures is discussed. 
2.3 .I. Bone density and bone loss 
a. Measurement of bone density: 
Since Albright. many radiological techniques have been developed for non-
invasive measurement of the amount of bone tissue in the skeleton. Present day 
technology allows measurement of the mineral content both of the entire 
skeleton and at particular sites of the skeleton. These measurements range from 
simple observations on radiographs to the application of sophisticated techniques 
such as quantitative computer tomography or neutron activation analysis. An 
overview of techniques has been given by Kimmel in 1984. 14 Techniques for 
measUJing bone tissue in the peripheral skeleton have been available for several 
decades. Techniques for measuring total body calcium or mineral content of the 
axial skeleton were developed more recently. 
Measurements of the bone mineral content at a single site of the skeleton are 
commonly used as an indicator of individual bone density on the assumption 
that the site selected will be representative for the remainder of the skeleton. 
This assumption is inconect. as was demonstrated by Aitken et al. in a study of 
the amount of bone per unit of volume (bone density) at different skeletal sites 
in male and female cadavers. 15 Bone density at peripheral sites of the skeleton 
was found to be only moderately correlated to bone density at the vertebral 
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collumn. For metacarpal bone density. for example. the coefficient of correlation 
to vertebral bone density was only 0.47 in twenty-one female cadavers. This 
correlation is too low to characterise individual axial bone density by measuring 
the bone density at a peripheral site. However. for epidemiological purposes. a 
peripheral measurement can be used for comparisons between groups with a high 
or low bone mineral content of the skeleton on average. 
b. Measurement of bone loss: 
In theory. it is possible to study the actual process of bone loss longitu-
dinally by measuring the bone mineral content of the skeleton at consecutive 
points in times. In practice. this approach has been seldomly applied. because 
the amount of bone tissue that is lost over a period of time is only a small 
percentage of the amount that is present. For detection of a difference in bone 
mineral content over time. either the measurement technique must be extremely 
accurate or the time period between the measurements must be rather long. 
Most inferences about bone loss have therefore been made on the basis of 
cross-sectional data. by comparing the bone mineral content of groups of 
individuals in various circumstances. e.g. age groups. 
c. Determinants of bone density: 
Age and sex are the two most important single determinants of bone density. 
ln general. there is an increase in the amount of bone tissue in the skeleton in 
early life and a decrease later on. both in men and women. The amount of bone 
tissue at any given age is the resultant of the amount initially laid down ("peak 
bone mass"). minus the amount that is lost later on. From cross-sectional 
investigations of bone density it has been inferred that bone Joss occurs as a 
universal phenomenon in middle aged and elderly individuals. In females the 
process stmis at an earlier age and the rate of loss is larger than in males. 16 
It has been suggested that bone loss in the axial and peripheral skeleton occurs 
in different patterns. In males bone loss from the peripheral skeleton begins 
between 40 and 55 years of age and the rate of loss has been estimated 
between 0.3 and 0.5 per cent per year. In females bone loss from the peripheral 
skeleton begins between 35 and 50 years of age. Before 50 years the rate of 
loss has been estimated between 0.2 and 0.4 per cent per year and after 50 
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Table II 
Supposed major risk factors of osteoporosis in women.3 
Postmenopausal (within 20 years after menopause) 
White or asian 
Premature menopause 
Positive family history 
Short stature and small bones 
Leanness 
Low calcium intake 
Inactivity 
Nulliparity 
Gastric or small-bowel resection 
Long-term glucocorticoid therapy 
Long-term use of anticoagulants 
Hyperparathyroidism 
Thyrotoxicosis 
Smoking 
Heavy alcohol use 
years of age between 0.8 and l.2 per cent per year. Bone loss from the axial 
skeleton may begin at an earlier age and the sex difference may be less 
pronounced. 
Besides age and sex. many other factors have been studied in relation to bone 
density. A list of supposed major risk factors of osteoporosis in women. as 
described by Riggs et al .. is presented in Table ll. 3 A detailed discussion of risk 
factors has been given in 1985 by Cummings et al.. 2 
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2.3.2. Epidemiology of fractures 
An increased risk of fractures may be considered as the most important 
clinical feature of osteoporosis. In the present paragraph the epidemiology of 
fractures will be described in relation to age and sex. 
The age and sex specific incidence of fractures have been estimated in two 
population based investigations. First. the incidence of fractures of the limbs 
has been investigated in the United States by Garraway et al. in 1979. 17 It is 
the only relatively complete study of fracture incidence rates in a population 
containing all age and sex groups. The case register of the Mayo Clinics was 
used to identify all cases of fractures of the peripheral skeleton that were 
treated in the hospitals of Rochester (Ro). Minnesota. In the line diagram in 
Figure I the age specific incidence rates for males and females are presented. 
Limb fractures occurred most often in younger males and older females. The 
average fracture incidence rates were 18.4 per 1000 person-years for males and 
14.0 per 1000 person-years for females. For the population aged 35 years and 
over the incidence rates were 12.5 and 18.9 respectively. An age related 
increase in fracture incidence rate was present in both elderly males and 
females. but in females the increase started at an earlier age. In males the 
fracture incidence started to increase after the age of 75 years. from 11.2 per 
1000 person-years. up to 32.6 per 1000 person-years in the group aged 85 years 
and over. In females the fracture incidence started to increase after the age of 
45 years from 7.3 per 1000 person-years up to 40.0 per 1000 person-years in the 
group aged 85 years and over. In the Rochester study age and sex specific 
incidence rates were not given for fractures at particular sites of the skeleton. 
Site specific incidence rates were studied by Knowelden et a!. in the United 
Kingdom in 1964. 18 Here. the study population had been restricted to individuals 
aged 35 years and over. The registers of the centralised services dealing with 
all fractures in Oxford and Dundee (O&D) were used to identify the fracture 
cases in the two regions. In the stack diagram in Figure I the age specific 
incidence rates for males and females are presented for various common types 
of fractures. The top of each bar represents the total age and sex specific 
fracture incidence rates. In compaJison to Rochester the total incidence rates 
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Figure I 
Age specific fracture incidence r;llt·~ in nwil'~ and knwil'~. The line diagram 
represents data from the population ol Roche~ter (Rol. liSA 17 Tht: histogram 
represents combined data from the population of Oxronl ;1nd Dundee CO&D). 
lfK 1 x Site specific rates are presented ror O&D for femoral neck (llip). lorearm 
(F.arm). hand and feet (H&Ft) and other fractures. 
Incidence rate per 1000 men-years 
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were lower at all ages. The reason for this is unclear. but it has been sugges-
ted that the study population had been not so well defined. 18 The incidence 
rates of all fractures in this population were I 0. 0 per 1000 person-years for 
males and 9.3 per 1000 person-years for females. The incidence rates of limb 
fractures were 9.2 and 8.9 respectively. Fractures of the small bones of hand 
and feet were more common in males than in females. Conversely. fractures of 
the distal forearm were more common in females than in males. Up to age 65 
the age related increase in fractures rates in women could be largely ascribed 
to an increase in the incidence of foreaJm fractures. After the age of 65 years 
hip fractures became increasingly important. both in males and in females. After 
the age of 85 years hip fractures were the most frequently occurring single 
type of fractures. 
An age related increase in fracture incidence rates has been described for 
several other specific sites of the skeleton including the humerus. 19 ankle.20 
and pelvis. 21 Fractures at these sites occur less frequently as compared to 
forearm and femoral neck fractures. 
The epidemiology of vertebral fractures deserves a separate discussion. 
Vertebral fractures have been considered as the classical type of osteoporotic 
fractures. but reliable data on the incidence of these fractures in the general 
population are not available. Incidence data are difficult to obtain. because 
many of these fractures occur without prominent symptoms. As a consequence. 
only a limited proportion of all vertebral fractures will come to the attention of 
medical services. As a further complication. there is no general agreement about 
the criteria for the diagnosis of ve1iebral fractures. 
Data on the prevalence of vertebral fractures are available from three 
population based studies. Since it is unlikely for vertebral fractures to heal 
without leaving traces. these data can be considered as an estimation of the 
cumulative incidence. 
Firstly. the age specific prevalence of vertebral fractures vvas estimated m 
1966 by Smith et al. in a population of 2063 females from Michigan. aged 45 to 
90 years. 22 The women were selected from hospital personnel and outpatients. 
The prevalence of compression fractures of the lumbar vertebral bodies was 
found to increase in relation to age from 0. 7 per cent for women aged 45 to 49 
years up to 16.7 per cent for women aged 70 to 74 years. In a follow-up study 
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of these women by Iskrant et al. 20 women repmied (!) spinal fractures over an 
average follow-up period of 4.3 years (883 I women-years). The estimated 
reported incidence of vertebral fractures was 2.3 per 1000 women-years. 23 The 
true incidence must have been higher. 
Secondly. the prevalence of complete (crush) and pmiial (wedge) compression 
fractures of the thoracic and lumbar spine was estimated in I 982 by Jensen et 
al. in a sample from the general population of 285 Danish women aged 70 
years. 24 In this study a prevalence of 4.6 per cent was found for complete 
compression fractures and 18.2 per cent for partial compression fractures. 
Thirdly. the prevalence of crush fractures of the lumbar spine was estimated 
in 1980 by Valkenburg et al. in the EPOZ-investigation in a sample from the 
general population of I 593 males and I 843 females from a Dutch population aged 
Figure II 
Age specific prevalence of crush fractures of the vertebral bodies Tl2 to L5. in 
a representative sample of 1593 males and 1843 females from a Dutch popula-
tion. (EPOZ 1975-1978). 25 
Prevalence (%) 
7%.-------------------------~-------------------------, 
6% 
35- 45- 55- 65- 75+ 35+ 35- 45- 55- 65- 75+ 35+ 
Age (years) Age (years) 
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35 years and older. 25 At present. these figures represent the only estimation of 
the prevalence of vertebral fractures among males. The group of females that 
was 45 to 64 years of age was used as the baseline population in the investi-
gation described in this thesis. The age and sex specific percentages of crush 
fractures of the vertebral bodies T12 to L5 are presented in Figure II. These 
results were obtained from routine readings of the films for back disorders. For 
males and females aged 35 years and older the total prevalence of ve1tebral 
crush fractures was similar. In males it appeared that many of the fractures 
occun-ed before 65 years of age and after 75 years of age. In females the 
majority of fractures occurred after 55 years of age. Presumably. some of the 
vertebral fractures in younger males resulted from accidents at work. 
2.3.3. Relationship between bone density and fractures 
In the previous two sections an age related decrease in bone density and a 
parallel increase in fracture rate were described. Since the main clinical charac-
teristic of osteoporosis is an increased risk of fractures due to a decreased 
bone density. the relationship between the two will be discussed in the present 
paragraph. 
a. Theoretical argumentation: 
From a bio-mechanical point of view any bone will fracture if a sufficient 
force is applied. In laboratory studies a direct relationship has been demon-
strated between the bone density of a particular bone and the forces it can 
withstand. For example. in a postmo1tem study of 17 radii of female subjects 
who were 39 to 95 years old at the time of death. the coefficient of correlation 
between the load necessary to produce a fracture and the bone mineral content 
was 0.83.26 In a similar study of 61 femoral neck autopsy specimens the 
coefficient of correlation was 0.89.27 Similarly. for trabecular bone the com-
pressive strength has been found to be proportional to the square of the 
apparent density of the bone. 28 Thus. the risk of a fracture for a particular 
bone will depend on the actual bone density and on the risk of a sufficient 
force being applied to that particular bone. 
30 
b. Empirical argumentation: 
As clesclibed previously. it has been established that bone density declines and 
fracture risk increases in relation to age. In females bone density declines by 
approximately 30 per cent between 45 and 75 years of age. At the same time. 
there is an approximate fomfolcl increase in fracture risk. From the theoretical 
point of view. it will be very likely that bone loss does contribute to the 
occurrence of fractures in the elderly. However. besides bone loss. many other 
age related factors may contribute to an increased fracture risk as well. For 
example. the quality of the motor system declines with age. The frequency of 
falls increases and protective reflexes that modify the way of falling become 
less effective in the elderly. 29 Furthermore. the fat and muscular tissue 
surrounding the skeleton as a protective shield will become less effective clue to 
atrophy. Also. the mechanical properties of the bone tissue as a matelial 
declines in relation to age. For femoral bone specimens it has been found that 
the tissue becomes more brittle in the elderly in a sense that the material 
would rather break than bend?° Finally. for trabecular bone ce1iain structural 
factors have been suggested to influence the mechanical strength. 31 
The intermingling of a multitude of factors that are subject to age related 
change. makes it difficult to make an empirical estimation of the contribution 
of bone density as a separate factor in fracture causation. The importance of 
the loss of bone as a cause of the age related increase in fracture risk would 
be overestimated if these factors were neglected. On the other hand. if an 
attempt is made to control for these factors by standardising for age. the 
contribution of age related bone loss will be underestimated. since at a similar 
age. bone loss will have occuned both in the fracture patients and in the 
non-fracture controls. 
The literature concerning the relationship between bone density and fracture 
risk has recently been reviewed by Cummings et al. (1986). 32 In two investiga-
tions the relationship between bone density and fracture occurrence has been 
studied prospectively. 
Firstly. in a study by lskrant et a!.. spinal bone density was rated subjec-
tively on lumbar spine radiographs of 2088 Michigan women aged 45 years and 
over.
23 The incidence of all fractures was estimated during an average peliod of 
4.2 years of follow-up. The total fracture incidence rate was 37 per 1000 
31 
women-years. which is relatively high. In ten year strata of age. the risk of 
fractures was approximately twice as high for women with a low spinal bone 
density as compared to women with a high bone density. 
Secondly. in 1981 Wasnich et at. have started a prospective investigation 
among I 098 Japanese-American women from Hawaii. aged 43 to 80 years. Bone 
mineral content was measured by photon absorptiometry in the proximal and 
distal forearm. in the os calcis and for a selection of the women in the lumbar 
spine. An interim rep01i based on 26 incident fractures was presentee! in 1985.33 
Fractures of the forearm and the ribs occurred most frequently. The estimated 
incidence rate of non-spinal fractures was 8.3 per 1000 women-years. which is 
relatively low. The age adjusted fracture odds ratio for the highest and lowest 
quintiles of bone mineral content was 4.1 for measurements in the distal radius 
and 10.3 for measurements in the os calcis. 
Several case-control studies have been conducted. comparing the bone density 
in inclivicluals with specific types of fracture to non-fracture controls. For 
subjects who had forearm fractures the bone mineral content of the contra-
lateral forearm has been found (only) 7% lower as comparee! to age-matched 
controls. 34 In a critical review of 15 case-control studies for femoral neck 
fractures. Cummings ( 1984) concluded that "the most rigorously designed studies 
observed less bone density in the hips of patients with fractures than in the 
hips of control subjects. but the differences were small and overlapping. "35 For 
cases with vertebral fractures the ve1iebral bone mineral content has been 
found considerably lower as compared to age-adjusted controls. In a study by 
Krolner et al. approximately one third of 72 cases with vertebral compression 
fractures had a mineral content of the spine below the 95% range for age-
matched controls. 36 The difference in bone mineral content between vertebral 
fracture cases and age-matched controls was less pronounced if the measure-
ments were made in the forearm. 37 
In conclusion. the relationship between bone density and fracture risk appears 
to be well established. However. there is considerable reason for doubting the 
idea that individuals with fractures constitute a separate population of "osteo-
porotic" patients. The age related increase in fracture rate may be explained in 
part by the universal age related bone Joss. but most likely other factors do 
32 
contribute as well. If these factors are neglected. the influence of age related 
bone loss will be overestimated. If an adjustment for age is applied. the 
influence of the universal occurrence of bone loss will be underestimated. 
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3.1. Introduction 
Chapter 3 
Architecture of the investigation 
The investigation that is the subject of this thesis can be characterised as a 
cohort study with a forward directionality and a nine year period of follow-up. 1 
A group of 1167 women aged 45 to 64 years was investigated for a first time 
between 1975 and 1978 as a part of the Epidemiological Preventive Investigation 
Zoetermeer. which is known by the Dutch acronym EPOZ. The same women 
were invited for a second investigation in 1985 and 1986. 
The investigation permitted several types of evaluation. Firstly. putative risk 
factors of osteoporosis that were present at the time of the initial investigation 
were related to the subsequent occurrence of fractures dwing the period of 
follow-up. This evaluation constituted the main reason for conducting the 
investigation. The results are presented in chapter four. 
Secondly. the occuJTence of age related bone loss was evaluated in a cross-
sectional and in a longitudinal way. The longitudinal data were used to evaluate 
the presence of differences in the rate of bone loss between individuals. The 
results of the evaluation are presented in chapter five. 
Thirdly. the forward study design was invetted to evaluate endogenous 
oestrogen activity in relation to bone density. bone loss and fractures. Endo-
genous oestrogen activity was measured at follow-up. It was related to bone 
density in a cross-sectional analysis. and to the occurrence of bone loss and 
fractures in a retrospective analysis. The latter approach of a retrospective 
cohort design with a backward directionality can be compared to the case-
control design. The subjects with high bone loss and/or fractures can be 
conceived as the "cases" and the remaining population as the non-diseased 
"controls". The approach was considered valid under the assumption that 
endogenous oestrogen activity was not influenced by bone density. bone loss. 
fractures or selective non-response at follow-up. nor by an unknown third 
factor influencing either of these. The results of the evaluation are presented 
in chapter six. 
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The cohort design has specific advantages and disadvantages. that are 
described in more detail in the epidemiological handbooks. 2 In the present 
situation. the population approach represented a natural imitation of the 
situation of normal middle-aged females visiting a general practitioner for 
advise about prevention of osteoporosis. Both the potential efficiency of selec-
tion of a "high-risk" group of women for preventive measures and the impact of 
fracture occurrence could be evaluated. An unavoidable disadvantage of the 
approach was that information was limited for events of infrequent occurrence. 
3.2. Population and methods 
The present investigation started with baseline information about risk factors 
of osteoporosis from the EPOZ survey. which took place between 1975 and 
1978.3 In the EPOZ-survey the inhabitants of two suburbs of Zoetermeer. a 
Dutch town near The Hague. were medically investigated for a study of 
prevalence and determinants of chronic disorders. such as cardiovascular. 
pulmonary, renal and rheumatic disorders. A total number of 13,462 individuals 
of all ages were invited and 10.532 (78 %) individuals participated in this 
survey. In 1985 and 1986. the female participants who were 45 to 64 years of 
age at the time of the EPOZ-survey were invited for a follow-up investigation 
to obtain information concerning bone loss and incident i.e. newly occuning 
fractures since EPOZ. This specific study group was chosen for several reasons. 
Osteoporosis is particularly frequent among middle-aged and elderly females. Age 
related bone loss starts at an earlier age and proceeds at a higher rate in 
females than in males.4 Also. the age specific fracture incidence is considerably 
higher in elderly females than in elderly males.5 In addition, the group of 
middle aged women was chosen for this study. because it is for this group that 
oestrogen replacement therapy is propagated as an effective strategy for 
prevention of fractures. 
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3.2.1. Period of follow-up and response rate 
The period of follow-up was calculatecl for the group of women for whom 
fracture information was available at the end of the study. The period ranged 
from 7 to 10 years. with an average and standard deviation of 9.0 ± 0.8 years. 
At baseline the average age of the women was 53.5 ± 5.8 years. At follow-up. 
the women were 53 to 76 years of age. with an average and standard deviation 
of 62.5 ± 5.8 years. 
The total number of women aged 45 to 64 years that participated in the 
EPOZ-survey was 1167 and the response rate among these women was 78 per 
cent. At the time of follow-up. 71 of these women had died and 87 had moved 
out of the town of Zoetermeer. Of the remaining 1009 women. 855 (85 %) 
participated in the complete follow-up investigation. For those women who 
moved out of the town of Zoetermeer or who refused participation. a fracture 
history was obtained by telephone. In this way. a fracture history was reco-
vered for I 014 women. which is 93 per cent of the women who were alive at 
the time of follow-up. The strategy of inviting women for the follow-up 
investigation is clescribecl in further detail in chapter seven. 
3.2.2. Information at baseline: EPOZ (1975-1978) 
In the EPOZ-survey a variety of information was collected by questionnaire. 
physical examination. radiological examination and serum analyses. From the 
questionnaire. information was used concerning chronological age. age and 
circumstances of menopause. age of menarche and smoking habits. Body height 
and weight hac\ been measured without shoes. but with indoor clothing: the 
Quetelet-inclex (body mass) was calculated as the ratio of body weight and 
height squared. Radiographs were available for most joints and joint groups. 
Antero-posterior radiographs of the hands were used for measurement of the 
diameter of the distal forearm. Bone density was determined in a classical way. 
by measuring the cortical thickness of the metacarpal bones (Metacarpal 
Racliogrammetry). Measurements of the outer diameter (D) and medullar diameter 
(c\) were made at the mid-shaft of the metacarpal bones 11. III and IV of both 
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hands. using a 7 times magnifying measurement Ioupe with an accuracy of 
0.0 I mm (Figure I). The Metacarpal Cortical Area (MCA) was calculated as the 
mean value of D2 -cl2 for six metacarpals and the Relative Cortical Area (RCA) 
was calculated as the mean value of 100 x (D2-d2)/D2 of six metacarpals.6 ·7 
Considerations for the choice of the metacarpal indices are given below. 
Lateral radiographs of the lumbar spine (TI2 to L5) were used for detection 
of osteoporotic deformations of the vertebral bodies. 8 A wedge deformation was 
considered to be present if the ratio of anterior to posterior height of the 
vertebral body was less than 0. 8 with intact end plates. This definition is 
relatively conservative.9 A crush deformation was considered to be present if an 
end plate was crushed or if the total vertebral body had collapsed. Antero-
posterior radiographs of the knees were used for measurement of the diameter 
of the knees at the level of the femoral epicondyles. 
3.2.3. Follow-up (1985-1986) 
The follow-up investigation included a questionnaire. a physical examination. a 
radiological examination and withdrawal of a serum sample. The follow-up 
investigation was designed to collect information about the occurrence of 
fractures since the initial EPOZ-survey. In addition. information was collected 
concerning number of children, history of lactation. age and circumstances of 
menopause and use of postmenopausal oestrogens. Radiographs of the hands were 
repeated for the purpose of follow-up Metacarpal Radiogrammetry. Lateral 
radiographs of the lumbar spine were repeated for detection of incident 
vertebral fractures. The serum samples that were taken were used for a 
multitude of biochemical measurements including serum concentration of 
oestrone. oestradiol. androstenedione and sex h01mone binding globulin (SHBG). 
Additional information that was collected. but not used for the evaluations 
presented in this thesis. is described in chapter seven. An english translation of 
the questionnaire that was used for the follow-up investigation is included in 
the appendix. 
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a. Fractures: 
A history of non-veiiebral fractures during the 9-year study period was 
obtained by questionnaire. The presence of incident deformations of the 
vertebral bodies of T 12 to L5 was detected by comparison of the initial and 
follow-up radiographs of the lumbar spine. The definition of prevalent vertebral 
defOimations was described above. Incident vertebral fractures were considered 
to be present during the study period if: I). a new deformation became appa-
rent. 2). a wedge defmmation changed into a crush deformation. or 3). the 
antero-posterior ratio of a wedge deformation decreased by 0.2 or more. 
b. Bone loss: 
Antero-postetior radiographs of the hands were repeated for follow-up 
metacarpal measurements. For the Relative Cortical Area the total loss during 
the study period was calculated by subtracting the initial measurements from 
those at follow-up. Since loss in RCA started around the age of menopause in 
our cross-sectional data. the annual rate of loss in RCA (change-in-RCA) was 
calculated as the total loss divided by the postmenopausal period during follow-
up. For the subjects who were already postmenopausal at the initial investiga-
tion (69 per cent of the 799 women for whom both initial and follow-up 
radiographs were available) this period was equal to the study period. For those 
who became postmenopausal during the study period (the remaining 31 per cent). 
this period was shorter. The average and standard deviation of the postmeno-
pausal period during follow-up were 7. 9 ± 2.1 years for the total group. 
As an illustration, details of the initial and follow-up radiographs of the left 
hand of the same subject are reproduced in Figure I. The woman of whom these 
radiographs were made was 50 years of age at the time of the first examination 
and 58 years at the time of the second investigation. RCA-1 was 88 mm2 % and 
RCA-2 was 66 mm2 %: the period of follow-up was 8.2 years: the postmenopausal 
peiiod during follow-up was similar. since the last menstruation had occurred 
before the first examination at age 48. The annual rate of loss in RCA 
(change-in-RCA) was -2.7 mm2 % (-3.0 % of the initial RCA). 
c. Endogenous oestrogens: 
Serum samples drawn at follow-up were used for duplicate measurements of 
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Figure I 
Detail of the initial (A) and follow-up (B) 
individual. The intervening period between 
D =outer diameter: d =medullar diameter at 
(EPOZ Follow-up Osteoporosis). 
A. 
B. 
44 
radiograph of the hands of the same 
the two radiographs was 8.2 years. 
the mid-shaft of the metacarpal bone. 
Photographs by T. Rijsdijk 
oestrone. oestradiol. sex hormone binding globulin (SHBG) and androstenedione 
concentrations. Oestrone concentrations were measured by means of a radio-
immuno-assay (RIA). after extraction of the serum on LH-20 microcolumns. 
using the antiserum as described by Van Landeghem et a!.. 10 The intra-assay 
variability was 13.2 per cent and the inter-assay variability was 18.4 per cent. 
Oestradiol concentrations were measured by means of a RIA. using a commercial 
kit supplied by Diagnostic Products Corporation (Los Angeles. California. USA). 
The intra-assay variability was 14.6 per cent and the inter-assay variability was 
I 8.5 per cent. Androstenedione concentrations were measured by means of a RIA 
using a commercial kit supplied by Eurodiagnostics (Apeldoorn. The Nether-
lands). The intra-assay variability was I 0.8 per cent and the inter-assay varia-
bility was I 6.5 per cent. SHBG was measured as described by Hammond et al.. 11 
The intra-assay variability was I I .4 per cent and the inter-assay variability was 
1 7. 8 per cent. 
3.3. Metacarpal Radiogrammetry 
In the past few decades a multitude of techniques have been developed for 
non-invasive measurements of the amount of bone tissue in the skeleton. 12 
Measurements can be made in the axial or in the peripheral skeleton. Dual 
Photon Absorptiometry (DPA) or Quantitative Computer Tomography (QCT) can 
be used for measurements of the amount of (aancellous) bone in the axial 
skeleton. Both these techniques are not well fit for population surveys. because 
they are expensive. time-consuming and require specialised equipment. For large 
scale epidemiological investigation bone measurements will usually have to be 
limited to the petipheral skeleton. The techniques most commonly used measure-
ments are Single Photon Absorptiometry (SPA) and Metacarpal Radiogrammetry. 
The latter technique was employed in the present investigation. It offered the 
unique opportunity to evaluate data from a large population over a long period 
of follow-up. 
The technique of Metacarpal Radiogrammetry is a simple method of quanti-
fying the amount of bone tissue in the metacarpal bones. It requires very little 
technical facilities. 
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3.3 .1. Metacarpal indices 
Once the measurements of the outer (D) and inner (d) diameter of the 
metacarpal bones have been made. two slightly different approaches can be 
followed to calculate indices of metacarpal bone mass. The first approach was 
described by Barnett and Nordin and constitutes of the calculation of the Meta-
carpal Cortical Thickness (MCT) of the metacarpal bones: D-el . 13 The second 
approach was described by Gam et a!. and constitutes of the calculation of 
Metacarpal Cortical Area (MCA): D2-d2 .6 As a standardization for differences 
in body size the Relative Cortical Thickness (RCT) and Relative Cortical Area 
(RCA) can be calculated for both approaches. This is clone by expressing MCT 
anc\ MCA as a percentage of the size of the metacarpal bone: lOOx(D-cl)/D and 
2 2 2 * IOOx(D -cl )/D respectively. Thus. the amount of metacarpal bone can be 
expressed as the thickness or as the cross-sectional area of the cortex; both 
can be expressed as absolute mass (MCT and MCA) or as relative density (RCT 
and RCA). The relationship between the indices in our own baseline data is 
demonstrated in Table I. where the coefficients of correlation between MCT. 
MCA. RCT and RCA are presented. Baseline data for Metacarpal Radiogrammetry 
were available for 1134 women. 
In the present investigation. MCA was preferred over MCT. because the 
former has a superior correlation to the amount of bone tissue that is actually 
present in the metacarpal bones as was demonstrated by Exton-Smith et a1.. 14 
In this post-mortem study. the metacarpal indices were coiTelated to the 
mineral content as estimated by ashing the shaft of the metacarpal bone at 600 
degrees Celsius. For MCA the correlation to ash content was 0.85; for MCT only 
0.31. 
The arguments for the choice between the MCA and RCA were not so clear-
cut. Absolute co11ical area can be interpreted as an indicator of the absolute 
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* The two relati\·e indices are mathematically equivalent: 
If RCT' = (D-d)/D [!] then 1-RCT' = diD 
If RCA'= (D2-d2)/D2 then RCA' = (D-d)/D x (1 +diD) 
Through substitution of [I] and [2] in [3] it follows that 
RCA'= RCT' x (I +(1-RCT') or RCA'= 2RCT'-RCT' 2 
[2] 
[3] 
Table I 
Coefficients of correlation of Metacarpal Cortical Thickness (MCT). Metacarpal 
Cortical Area (MCA). Relative Cortical Thickness (MCT) and Relative Cortical 
Area (RCA) among 1134 women aged 45 to 64 years. (EPOZ 1975-78). 
RCA RCT MCA MCT 
MCT 0.79 0.91 0.86 1.00 
MCA 0.45 0.59 1.00 
RCT 0.95 1.00 
RCA 1.00 
MCT = D-d. MCA = D2-d2. RCT = I OOx(D-d)/D. RCA = I OOx (D2 -d2) !D2 
D = Outer diameter. d = Medullar diameter of metacarpal bone 
amount of bone that is present (bone mass) and relative cortical area can be 
interpreted as the amount of bone per unit of volume (bone density). The first 
will be dependent on body size, whereas the latter is standardized for differen-
ces in body size. The influence of body size on MCA and RCA could be demon-
strated empirically in our own data. Metacarpal Cortical Area was correlated 
significantly to body length (r=0.33; p<O.OOI). Relative Cortical Area was 
unrelated to body length (r=-0.01; not sign.). 
In theory, skeletal strength and fracture risk may depend both on bone mass 
(size of the skeleton) and on bone density. Therefor, both MCA (bone mass) and 
RCA (bone density) were used in the analysis of fracture risk as presented in 
chapter four. However, in a comparison of the amount of bone tissue between 
individuals, the size of the skeleton will act as a disturbing factor. As a 
consequence. RCA was preferred for the comparisons between individuals that 
were made in the chapters five and six. 
For comparisons between different studies, RCA will be more informative than 
MCA, since the latter is very sensitive for variation in the projection of the 
hand on the radiograph due to variation in the tube-hand-film distances. 
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3.3.2 Validity of Metacarpal Radiogrammetry 
As a method of measuring the amount of bone tissue. Metacarpal Radiogram-
metry has been criticised for several reasons. 15 
Firstly. it has been claimed that the measurement precision of Metacarpal 
Radiogrammetry is unsatisfactory. This may be true for measurements of a 
single metacarpal bone. for which a precision of 5 to I 0 per cent has been 
reported. However, for multiple measurements of six metacarpal bones the 
precJSJOn is much better. Values between I and 3 per cent have been repor-
ted.16 For comparison. the precision of Single Photon Absorptiometry has been 
reported to be I to 2 per cent in laboratory conditions and 2 to 5 per cent in 
clinical circumstances. In the present investigation. the measurement precision 
was estimated in I 00 duplicate measurements. The mean intra-individual standard 
deviation of a duplicate measurement was I. 9 mm2 ( 4 %) for M CA and 2.5 mm2 % 
(3 %) for RCA. It is concluded that Metacarpal Radiogrammetry is sufficiently 
precise to allow for meaningful comparisons of bone density between individuals. 
For detection of bone Joss. the method is only suitable in long-term follow-up 
studies. 
Secondly. the accuracy of the method has been doubted. lt has been sug-
gested. that the method does not accurately measure what it intends to 
measure. i.e. the amount of bone tissue in the metacarpals. This may be true 
for some of the metacarpal indices. but for the Metacarpal Cortical Area a 
reasonable co1Telation to the ash mineral content has been established. as was 
described in the previous section. 
Thirdly. the strength of the correlation between metacarpal bone mass and 
bone mass at other sites of the skeleton has been questioned. In a post-mortem 
study. Aitken et a!. found moderate to high correlations between ash mineral 
content of the metacarpals and the ash mineral content of the veJiebral bodies 
(0.47). distal femur (0.84). distal radius (0.75). mid-shaft femur (0.85) and mid-
shaft radius (0.96) in females. 17 Thus. metacarpal cortical bone density is not 
very strongly related to bone density in the axial skeleton. but it is reasonably 
cotTelated to bone density at peripheral skeletal sites of cortical bone. More 
recently. Reinbold et a!. compared Metacarpal Cortical Thickness. SPA of the 
distal forea1m and DPA and QCT of the vertebral bodies. 18 Both for Metacarpal 
48 
Cortical Thickness and for SPA measurements of the distal forearm the correla-
tion to vertebral mineral density was around 0.50 for healthy women and around 
0.25 for women who had axial osteoporosis. In this respect. Metacarpal Cortical 
Thickness was not of inferior value as compared to SPA. Neither method 
appeared to be very useful for the detection of axial osteoporosis. 
Finally. it has been suggested that the validity of the measurements may be 
limited by a continuing age related gain of bone tissue at the outer smface of 
the metacarpal bone, as is reflected in a slow growth of the outer diameter of 
the bones. Since the outer diameter of the metacarpal bone (D) is considerably 
larger than the medullar diameter (d). a small increase in D (gain of bone) 
might compensate a much larger increase in d (loss of bone). In theory, MCA 
could remain unaltered. while RCA would decrease. The influence of growth of 
the metacarpal bone in relation to change in MCA and RCA was evaluated in 
our own longitudinal data. In the baseline data. the mean outer diameter of the 
six metacarpals was 8.0 mm. The age related increase in D was approximately 
0.1 % per year. The mean medullar diameter of the six metacarpals was 3. 7 mm 
and the age related increase in d was approximately l .5% per year. In the 
correlation matrix in Table II the relationships between changes in D (delta-D). 
d (delta-d). RCA (delta-RCA) and MCA (delta-MCA) were evaluated. All 
Table II 
Coefficients of correlation of the change in mean outer diameter of six 
metacarpals (delta-D), mean medullar diameter of 
Metacarpal Cortical Area (delta-MCA) and Relative 
over a period of nine years of follow-up among 799 
64 years. (EPOZ Follow-up Osteoporoses). 
six metacarpals (delta-d). 
Cortical Area (delta-RCA) 
women initially aged 45 to 
Del ta-D Delta-d Delta-MCA Delta-RCA 
Delta-RCA 
Delta-MCA 
Delta-d 
Del ta-D 
-0.09 
0.34 
0.23 
1.00 
-0.94 
-0.76 
1.00 
0.86 
1.00 
1.00 
49 
coefficients were significantly different from zero. Changes in RCA were 
predominantly determined by changes in d (bone loss) (r==-0.94; p< 0.00 I). 
Delta-RCA was only slightly related to delta-D (bone gain) (r==-0.09: p<0.05). 
Delta-MCA was also strongly determined by delta-d (r==-0.76: p<O.OOI). but to a 
lesser extent by delta-D as well (r=0.34: p<O.OOl). Apparently. the dynamic of 
change in both RCA and MCA was predominantly influenced by bone loss 
(delta-d). RCA was practically unaffected by bone gain (delta-D) and MCA was 
only moderately affected by bone gain. The significant conelation between 
delta-D and delta-d (r==0.23: p<O.OOl) was of interest. because it suggests that 
the processes of bone gain at the outer metacarpal surface and bone loss from 
the medullar metacarpal smface did not occur independently. 
In summary. the validity of Metacarpal Radiogrammetry has been questioned 
for several reasons. From the previous discussion it is concluded, that the 
precision and accuracy of the method are sufficient. The correlation of meta-
carpal bone density to bone density at other peripheral sites of the skeleton is 
reasonable and this correlation is not inferior to that of SPA of the distal 
radius. An age related growth of the outer diameter of the metacarpals was 
present in our study population. The growth of the metacarpal bone had 
practically no influence on delta-RCA and little on delta-MCA. For the purpose 
of short-term follow-up investigations of bone density in the pelipheral 
skeleton, Single Photon Absorptiometry of the distal forearm may be preferred 
rather than Metacarpal Radiogrammetry, considering the slightly better preci-
sion. For the purpose of the present epidemiological investigation with a long 
period of follow-up. Metacarpal Radiograrnmetry is probably not inferior to 
Single Photon Absorptiometry of the distal forearm. 
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Chapter 4 
Prediction of osteoporotic fractures in the general population by a 
Fracture Risk Score. A 9-year follow-up among middle aged women 
4.1. Introduction 
The occuiTence of skeletal fractures is very common among postmenopausal 
women. The incidence of limb fractures rises with age. from approximately 7.3 
per I 000 women years at age 45 to approximately 40 per I 000 women years at 
age 85 and over. 1 Reduced bone mass clue to postmenopausal bone loss may be a 
m<Yor contributing factor in the propensity of older bones to fracture. 
Both the process of bone loss and the occuiTence of fractures can be preven-
ted by long-term oestrogen replacement therapy. starting early after the 
menopause. This may lead to an estimated reduction in fracture occuiTence up 
to 60 per cent. 2 ·3 However. the question which women would benefit most from 
oestrogen treatment remains to be answered. 4 
In the past. much effort has been devoted to the search for risk factors of 
osteoporosis. Factors such as smoking. body size. age and circumstances of the 
menopause and reproductive history have all been implicated as possible 
predictors of osteopenia or fractures. It has been suggested that this knowledge 
may be used to select women for fracture prevention programmes.5 The present 
investigation was intended to evaluate the clinical efficiency of this approach 
an1ong middle aged women from the general population. 
Initial information about twelve historical and radiological risk factors of 
osteoporosis was collected among 1167 women aged 45 to 64 years. For the nine 
following years information was collected about all newly occurring fractures. 
The efficiency of initial risk factors in predicting subsequent fractures was 
evaluated. A Fracture Risk Score (FRS) was assembled from the best combina-
tion of risk factors. 6 Detailed information concerning the study design was 
presented in chapter three. 
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4.2 Statistics 
In the statistical analyses. subjects who had one or more missing values for 
any of the study variables were excluded. Complete data were available for 742 
women. The fracture rate among the subjects that were excluded because of 
missing data was similar to the fracture rate among the remaining subjects. The 
analysis was pe1formed for all fractures as a single group and. separately. for 
the group of type I osteoporotic fractures. (forearm and vertebral fractures). In 
Table I 
Mean values. standard deviations and 90 per cent ranges for the continuous. and 
proportions for the categorical risk factors. Data from 742 Dutch women aged 
45 to 64 years. (EPOZ I 975-1978). 
Continuous risk factors 
Percentiles 
Mean S.D 5th 95th 
Age (years) 53.5 5.2 46 63 
Metacarpal Cortical Area (mm2) 50.6 6.6 40 62 
RCA(% mm2) 78.5 7.6 65 90 
Quetelet index (kg/m2) 25.5 3.3 21 32 
Body height (em) 162.8 6.1 153 172 
Diameter of forearm (mm) 49.1 2.8 44 54 
Diameter of knee (mm) 85.4 4.1 79 92 
Age of menarche (years) 13.5 1.8 11 17 
Age of menopause (years) 47.7 4.9 39 54 
Categorical risk factors 
propmtions in percentages 
Smoking (cigarettes/day) none: 66 ~ 10: 19 L J 1: 15 
Number of children none: 13 1-4: 66 L 5: 21 
Period of lactation (months) none: 32 ~ 12: 43 L 13: 26 
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Table I the mean values and frequency distributions are shown for the risk 
factors that were studied. 
The nine year risk for one or more fractures was calculated in several 
categories of each risk factor. Age was categorised in 5-year groups of initial 
age. Smoking was cliviclecl in arbitrary categories: none. ~ I 0 or more than 10 
cigarettes per clay. MCA. RCA. Quetelet-index. body height. and diameter of the 
foreann and knee were categorised in tertiles. indicated as high. middle and low 
in the Figures. For age and circumstances of menopause the women were 
arbitrarily divided in the groups older and younger than 45 years: the latter 
group (early menopause) was further divided according to the cause of meno-
pause: natural. hysterectomy and oophorectomy. Menarcheal age was divided 
according to conventional age limits: younger then 12 years. 12 to 15 years and 
16 years and over. For history of lactation all periods were summed together to 
a total period. which was divided arbitrarily into categories: none. ~ 12 month 
and more than 12 months. Chi-Square statistics were used to test the statis-
tical significance of the differences in fracture risk between the categories of 
each risk factor. 
In a multivariate analysis the relationship between risk factors and fracture 
risk was combined in order to maximize predictive strength. Variables that 
discriminated best between individuals with and without fractures were selected 
and these variables were used to calculate an individual Fracture Risk Score. 
The selection of discriminatory vruiables was made by a stepwise multiple 
logistic regression procedure. 7 •8 Indicator variables were created for all the 
variable-categories that were desc1ibed above. In preliminary analysis initial age 
demonstrated to be an effect modifier for some of the risk factors. Therefore. 
interaction variables were created for each variable category and the age 
category 55 years and over. The principle of logistic regression analyses with 
indicator variables and the analysis of effect modification with interaction 
variables have been described in detail by Kleinbaum et al.. 9 Each indicator 
variable was allowed to enter into the model separately. using a stepwise 
selection procedure. The p-value limit for selection into the model was set to 
0.1 0. In this way a set of indicators with maximum discriminatory power was 
selected. 
A Fracture Risk Score was calculated for each individual by the equation: 
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FRS = exp(A)/( I +exp(A)). where A represents the sum of the intercept and the 
logistic regression coefficients of the indicators that were selected in the 
model. The FRS represents the maximum likelihood estimate of the individual 
fracture risk. To evaluate the accuracy of the FRS in predicting fractures the 
observed nine year fracture risk was calculated in quintiles of the score. To 
evaluate the stability of the prediction a single split-sample test was peifor-
med. 6 For this purpose the study population was randomly split in two samples 
of approximately equal size: The first sample was used to derive the logistic 
regression coefficients and the second sample was used to calculate the risk 
score and the observed fracture risk. 
4.3. Results 
a. Fractures: 
The fracture types and numbers are shown in Table II. Among I 014 women a 
total number of 203 fractures occurred in 16 I women. Of all fractures 92 were 
type I osteoporotic (forearm or vertebral) fractures and these occurred in 83 
women. The estimated incidence was 22.2 per !000 women-years for all fractures 
and 10.1 per 1000 women-years for type I osteoporotic fractures. More than a 
single fracture was reported by 32 women. The nine year risk for one or more 
fractures was 0. 16 for all fractures and 0.08 for osteoporotic fractures. Approxi-
mately 80 per cent of all fractures and 90 per cent of type I osteoporotic 
fractures occurred after a minimal trauma (e.g. fall from standing position) or 
without a known trauma (vertebral fractures). 
b. Risk factors: 
The nine year risk of one or more fractures in categories of each of the 
twelve risk factors is presented in the Figures I to III. For most risk factors 
the patterns of fracture risk were similar for all fractures and for type I 
osteoporotic fractures. 
The fracture risk increased consistently over the 5-year categories of initial 
age (Figure 1). The habit of smoking cigarettes appeared to be unrelated to 
fracture risk. although the proportion of osteoporotic fractures was relatively 
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Table II 
Type and number of fractures over nine years of follow-up among 
1014 middle aged Dutch women. (EPOZ Follow-up Osteoporosis). 
Skull 
Nasal bone 
Vertebral body 37 
Clavicula 3 
Scapula 2 
Rib 6 
Os sacrum 2 
Pelvis 4 
Upper arm 11 
Lower arm 7 
Forearm 55 
Hand & foot 44 
Femoral neck 2 
Upper leg 3 
Patella 4 
Lower leg 7 
Ankle 14 
Total 203 
high among the women smoking II or more cigarettes per day. For Metacarpal 
Cotiical Area (MCA). a "dose-response" type of relationship was present. but 
the contrast between the upper and lower tertiles was not very strong. For 
Relative Cotiical Area (RCA). the contrast in fracture risk was stronger than 
for MCA. but the dose-response relationship was absent. The contrast between 
both MCA and RCA tertiles was less pronounced after adjustment for age 
differences (not shown). In the group of risk factors representing body size 
(Figure II). Quetelet index and radiological diameter of the knee appeared to be 
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unrelated to fracture risk. For body height and radiological diameter of the 
forearm a relatively strong contrast was present between the middle and lower 
tertiles. Low body height and low (!) diameter of the forearm appeared to offer 
some protection against the occurrence of fractures. In the group of risk 
factors representing reproductive history (Figure III). the risk of type 
osteoporotic fractures seemed to be slightly increased in women who had a 
history of a late menarcheal age. a long period of lactation. or no children. For 
age and circumstances of the menopause. fracture risk was highest among the 
women who had an oophorectomy before age 45. However. quite contrary to 
common wisdom. fracture risk was lowest among the women who had an early 
natural menopause before age 45. 
In generaL the differences in fracture risk between the various risk cate-
gories were small. The differences were statistically significant (p<0.05) for age. 
RCA. body height and diameter of the forearm. both for all and for type I 
osteoporotic fractures. 
Information concerning the use of postmenopausal therapy was collected 
retrospectively in the follow-up investigation. Of 742 women with complete data. 
229 (31 %) reported the use of some form of postmenopausal therapy (either 
oestrogens. progestagens or androgens). The use was predominantly of short 
duration: less than one year for 123 women and 3 years or more for 54 women. 
No relationship was found between the use of postmenopausal therapy and the 
occurrence of fractures. The use of the therapy was significantly more frequent 
among women who reported a hysterectomy or an ovariectomy. It was not 
significantly related to the presence of any of the other risk factors. In order 
to maintain the forward directionality of the study design. the infom1ation was 
not included in the construction of the Fracture Risk Score. 
c. Fracture Risk Score: 
For the construction of a Fracture Risk Score. variable-categories were selected 
and combined. using a stepwise logistic regression technique. as described above. 
The variable-categories selected for all fractures were: low body height. both 
low and high diameter of the forearm and both low and high RCA. In addition. 
for women over 55 years only: total period of lactation > 12 months and having 
no children were selected. The latter two categories were associated with an 
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Figure I 
Nine year risk of all fractures and of Type osteoporotic fractures in catego-
ries of initial age. smoking. Metacarpal Cortical Area and Relative Cortical Area 
among 742 middle aged women. (EPOZ Follow-up Osteoporosis). 
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Figure II 
Nine year risk of all fractures and of Type osteoporotic fractures in catego-
ries of body size among 742 middle aged women. (EPOZ Follow-up Osteoporosis). 
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increased risk. whereas the other categories were relatively protective as 
compared to the referent categoties. which were complementary to the catego-
ries selected. The variable-categories selected for type I osteoporotic fractures 
were: low body height and age of menarche ~ 16 years. For women over 55 
years only: low MCA. total period of lactation > 12 months and having no 
children were selected as well. Here. all variable-categories with the exception 
of low body height were associated with an increased fracture risk. 
The variable-categories selected were used to calculate an individual FRS both 
for all and for type I osteoporotic fractures. The observed nine year fracture 
risk in quintiles of the FRS is presented in Figure IV. Results of a split sample 
test (sst) are included in the text in parentheses. The fracture risk ratio 
between the upper quintile versus the lower quintile was 6.4 (sst: 5.4) for all 
fractures and 7.0 (sst: 5.7) for type I osteoporotic fractures. The contrast in 
Figure IV 
Observed nine year risk of all fractures and of Type I osteoporotic fractures in 
quintiles of a Fracture Risk Score (FRS) among 742 middles aged women. (EPOZ 
Follow-up Osteoporosis). 
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Table III 
Number of subjects with and without fractures. in quintiles of the Fracture Risk 
Score (FRS). FRS 1-4 = Lower 4 risk quintiles: FRS 5 = Highest risk quintile: 
A. All fractures; B. Type I osteoporotic fractures. (EPOZ Follow-up Osteopo-
rosis). 
A. All fractures 
No fractures All fractures Total 
FRS 1-4 515 (84%) 79 (63%) 594 
FRS 5 101 (16%) 47 (37%) 148 
Total 616 (100%) 126 (100% 742 
B. Type osteoporotic fractures 
No Type I fractures Type I fractures Total 
FRS 1-4 560 (83%) 34 (52%) 594 
FRS 5 117 (17%) 31 (48%) 148 
Total 677 (100%) 65 (100%) 742 
fracture risk between the two extreme quintiles was statistically significant 
(p<0.005). However, if the upper quintile of the FRS were to be considered as a 
diagnostic test for predicting the occurrence of fractures the score was not 
very accurate. The number of individuals with and without fractures in the 
upper quintile versus the remaining quintiles of the Risk Score are presented in 
Table III. The upper FRS quintile contained no more than 3 7 per cent 
(sst: 32 %) of all fracture patients and 48 per cent (sst: 37 %) of type I osteo-
porotic fracture patients. The corresponding sensitivity and specificity of this 
prediction was 0.37 (sst: 0.32) and 0.84 (sst: 0.83) for all fractures and 0.48 (sst: 
0.37) and 0.83 (sst: 0.82) for type I osteoporotic fractures. 
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4.4. Comment 
The results of the present analyses can be summarised as follows. Inf01mation 
about single historical or radiological risk factors of osteoporosis is of little 
value in predicting the occurrence of fractures. The influence of several 1isk 
factors combined in a Fracture Risk Score resulted in a strong contrast between 
women with a high and a low risk of fractures. However. if the FRS were to be 
used to identify a high risk group of women. a selection of 20 per cent of all 
women between 45 and 64 years would contain less than 40 per cent of the 
fracture cases that occur in the general population during a nine year period. 
To qualify our results we need to discuss the quality of our inf01mation and 
procedures. Information about non-vertebral fractures was obtained by question-
naire. asking participants to remember their fracture history over the past nine 
years. The reliability of such a fracture history has been shown previously. 10 As 
a validation of our data we estimated the expected number of limb fractures for 
our population. using incidence figures from the population of Rochester. 1 The 
expected number of limb fractures was 173 (95% conf. limits: 148-200), which 
was not significantly different from the observed number of 149 (95% conf. 
limits: 125-174). 11 The number of incident. i.e. newly occurring vertebral 
fractures in our study population could not be compared to other populations, 
because these figures are not available. In our population we found these 
fractures to be second in frequency after forearm fractures. The real incidence 
will be higher. since we assessed the vertebral bodies T12 to L5 only. With the 
conservative criterion that was used, approximately half of the incident 
vertebral fractures were wedge in type. The majotity of women who had newly 
occurring vetiebral fractures were asymptomatic: only three of the women were 
attending their general practitioner for this reason. 
The limitations of our statistical procedure of constructing the FRS have to 
be borne in mind. The selection of tisk factors was made purely mathematically. 
from a pool of approximately 60 variable-categories. using the p-value of the 
association to fracture risk as the selection ctiterion. With this approach 
maximum predictive power was selected from the data. including spurious 
predictive power that could have been present due to coincidental relationships. 
If this procedure were used for the purpose of risk factor identification it could 
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be rightly criticised for the fact that "chance" relationships specific to the 
particular data would be wrongly identified as potential risk factors. However. 
the present investigation was not intended to identify risk factors. but to 
evaluate the (maximum) efficiency of the use of Iisk factors for clinical 
fracture prediction. At worst. the inclusion of coincidental relationships will 
result in an estimation of the predictive power that is too optimistic. The 
importance of these chance effects can be demonstrated in two ways: 1 ). in a 
simulated prediction and 2). in a split sample test of the real data. In a set of 
simulated data with a similar structure as our data. but with va1iables that were 
randomly generated. we found a sensitivity and a specificity of 0.35 and 0.8 I 
for "chance" prediction. In the split sample test the influence of coincidental 
relationships is reduced by deriving the prediction score from one half of the 
data. while testing it on the other half of the data. For the present data. both 
the contrast between the upper and lower quintiles of the FRS and the 
sensitivity and specificity of the predictions were reduced in the split sample 
test. Considering these limitation it must be expected that the pe1formance of 
the FRS will be even less if the same scores were used in entirely different 
populations. 
The present investigation demonstrates that the accuracy of fracture predic-
tion on the basis of twelve historical and radiological risk factors of osteo-
porosis is relatively poor. We may wonder whether a better prediction could be 
attained if other Iisk factors were used. A necessary requirement for these risk 
factors would be that they discriminate well between individuals with and 
without fractures. A sophisticated technique. like Quantitative CT measurement 
of the mineral mass of vertebral bodies indeed has some predictive value for 
the occurrence of vertebral fractures. 12 However. this technique is not appro-
piiate for population screening. For other measurement techniques at different 
sites of the skeleton. the overlap between fracture patients and normals has 
invaiiably been considerable and the use of these techniques for population 
screening has recently been discouraged. 13 
Next to the risk factors that were studied in the present investigation. other 
risk factors. such as low calcium consumption and physical activity have been 
suggested as risk indicators. because of an assumed influence on bone mass. 
Apart from the practical problem of the accurate measurement of these 
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variables. it seems unlikely that these factors will be strongly related to the 
occurrence of fractures. if bone mass is not. In the present investigation no 
relationship could be demonstrated between fracture occurrence and dietary 
calcium consumption that was estimated at follow-up. 
A multitude of relatively rare conditions such as gastro-intestinal resection. 
renal insufficiency or hyperparathyroidism may be more strongly related to frac-
ture risk. From a clinical point of view. these relationships could be impmiant. 
but it can not be expected that these rare conditions will contribute to 
prediction of the frequently occmTing fractures in the general population. It 
seems unlikely that any of the generally accepted risk factors of osteoporosis 
will be useful for an effective selection of women for fracture prevention 
programmes. 
In conclusion. we cannot propose an effective selection strategy for women at 
high risk of fractures. Recently. on the International Symposium of Osteoporosis 
in Aalborg. Denmark. a panel of experts came to a similar negative result. 4 In a 
reaction to this disappointing situation an editorial suggested that women and 
their doctors will have to continue to rely on the traditional risk factors. such 
as slender. small build and early menopause. 14 The main conclusion of the 
present investigation is that this approach is not to be recommended. It may be 
preferable. or at least more economic. 15 to advise oestrogen therapy to all 
women -if not contraindicated- shortly after the menopause. rather than 
selecting a subgroup of women on the basis of risk factors which hardly predict 
future fracture occun·ence. 
4.5. Summary of the chapter 
The possibility to predict the occurrence of skeletal fractures on the basis 
of risk factors of osteoporosis was evaluated in a follow-up study of I I 67 
women from the general population initially aged 45 to 64 years. During the 
nine years of follow-up I 6 per cent of the women expelienced one or more 
fractures. 
In separate analyses of twelve histmical and radiological 1isk factors which 
are considered important in the biomedical literature. none were found to be 
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strong indicators of future fractures; neither of all fractures, nor of type 
osteoporotic fractures (fractures of the vertebral bodies and distal foreann). 
A Fracture Risk Score (FRS) was calculated for each individual by combining 
the simultaneous influence of several risk factors in a multivariate analysis. The 
FRS disciiminatecl relatively well between women with a high and low risk of 
fractures. The risk ratio between the highest and the lowest FRS quintiles was 
6.4 for all fractures and 7.0 for type I osteoporotic fractures. However. if 
belonging to the highest quintile were to be considered as a screening test for 
fracture prediction the sensitivity and specificity were relatively poor: 0.38 and 
0.84 for all fractures and 0.47 and 0.83 for type I osteoporotic fractures. These 
results indicate that it might not be efficient to use risk factor status to select 
women for fracture prevention programmes. 
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Chapter 5 
Metacarpal bone loss in middle-aged women 
5. L Introduction 
Bone loss is a universal age related phenomenon. occurring both in men and 
women.
1 The loss of bone tissue from the skeleton will eventually lead to 
osteopenia. which is often held responsible for the increased frequency of 
fractures in the elderly. 
In 1941 Alb1ight et al. defined osteoporosis as a disease charactelised by "too 
little bone in the skeleton". This disease was supposed to originate from a 
defective function of the osteoblast.2 The concept of osteoporosis as a disease 
implies that some individuals are affected while others are spared. In 1970 this 
concept was challenged by Newton-John et al., who stated that in all individuals 
after a certain age. the rate of bone loss is of comparable magnitude. 3 Accor-
ding to this view osteopenia at old age is no more than a reflection of the 
level of bone density at a younger age. The argumentation of Newton-John was 
based on a review of cross-sectional studies of bone density. Valid longitudinal 
data were not available at that time and are still scarce. 
In the present population based investigation the occurrence of bone loss was 
investigated longitudinally. The rate of metacarpal bone loss was measured in 
799 women aged 45 to 64 years, who were followed for an average period of 
nine years. The occurrence of osteopenia, bone loss and individual differences in 
bone loss were evaluated. 
5.2. Theoretical considerations 
The purpose of the data analyses that were carried out was firstly to evaluate 
the existence of differences in the rate of bone loss between women and 
secondly to evaluate whether differences in the rate of bone loss were of rele-
vance for the occurrence of osteopenia. Some theoretical considerations 
concerning the statistical techniques are presented first. 
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5.2.1. Analysis of differences in bone loss 
Three approaches were used to evaluate the presence of differences in the 
rate of bone loss between women: a). comparison of standard deviations of bone 
density. b). estimation of the proportion of the variance in the rate of bone 
loss that could be ascribed to "true" loss and c). evaluation of the presence of 
the phenomenon of horse-racing. 
a. Comparison of standard deviations: 
The presence or absence of an age related change in the standard deviation of 
bone density has been interpreted by some as an indicator of the homogeneity 
between individuals of the process of bone loss. In I 972. Doyle described four 
different models of bone loss with their corresponding age related changes in 
the standard deviation (Figure I): 4 
I. A model of equal bone loss for all individuals, as was suggested by 
Newton-John and Morgan. 3 The standard deviation is unrelated to age. 
II. A model of a high rate of bone loss for individuals with a high initial 
bone density and a low rate of loss for individuals with a low initial bone 
density. This model was inferred from the writings of Albright and Reifen-
stein.5 The standard deviation diminishes progressively with age. 
III. The opposite model of a high rate of bone loss for individuals with a low 
initial bone density and a low rate of loss for individuals with a high 
initial bone density. Here, the standard deviation increases progressively 
with age. 
IV. A model of unequal bone loss with some women losing bone and others not 
losing bone. irrespective of initial level as was suggested by Adams et al.. 6 
Again. the standard deviation increases progressively with age. 
b. Longitudinal rate of bone loss: 
An intuitive approach of evaluating differences in the rate of bone loss between 
individuals is the calculation of the bone loss as it can be observed in a longi-
tudinal investigation. At first sight. these data represent exactly the infOJmation 
needed. However. there is a problem: the difference between an initial and a 
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Figure I 
Four models of bone loss according to Doyle (1972) .4 I. Similar loss for all 
individuals: II. High loss in relation to high initial bone density: III. High loss 
in relation to low initial bone density: IV. Loss for some individuals and not for 
others. irrespective of initial bone density. Each line in the figure represents a 
hypothetical individual course of age related bone loss. 
Modell RCA(mm 2~%~) ____________________________________ __ 
1 00 ,-------
Model II RCA (mm 2%) 
100.--------------------------------------------, 
90 90 
80 80 
70 70 
---------
60 60 
50 50 
40L-____ L_ ____ ~ ____ i_ ____ ~ ____ _L ____ _L ____ _J 40L_ ____ L_ ____ L_ __ ~----~----~----~----_J 
45 50 55 80 85 70 75 80 u w ~ oo ~ ro H oo 
Model ill RCA (mm 2%) 
100.-~------------------------------------------ 100 ~R=CA~(m~m~2~%~) ____________________________________ _ Model IV 
90 
---------------
90 
80 80 
70 70 
~ 
~-
60 60 
50 50 
40 40 
45 50 55 60 65 70 75 80 45 50 55 60 65 70 75 80 
Age (years) Age (years) 
follow-up measurement is not only determined by bone loss. but also by the 
measurement error. This problem is particularly relevant if the measurement 
error is relatively large as compared to "true" loss. As a consequence. direct 
measurements of individual changes in bone density are of limited value. As an 
alternative. the presence of "true" differences in the rate of bone loss can be 
demonstrated in groups. by estimating the "true" variance in bone loss. In the 
present evaluation this was done by subtracting the en-or vruiance. as estimated 
from I 00 duplicate measurements. from the total variance of bone loss that was 
observed in the study population. 7 
c. Horse-racing: 
A third method to evaluate the presence of differences in the rate of bone 
loss between women is an analysis of the relationship between the level of bone 
density and the rate of bone loss. With this approach. the influence on bone 
density of consistent. long term differences in the rate of bone loss can be 
evaluated. The technique of relating rate of change to initial value has been 
used previously in pulmonary function and blood pressure research. 8·9·10 The 
basic idea can be described as follows: if a subgroup of women is consistently 
losing bone at a relatively fast rate over a longer period of time. this subgroup 
will "shift down" to the lower part of the frequency distribution of bone 
density (Figure II). The other way around, if the fast bone loss continues, the 
women with the lowest bone density will demonstrate the highest loss. This 
relationship will grow stronger as the period over which the fast loss has 
occurred has been longer; i.e. in the elderly women. The phenomenon of a drift 
of individuals with a high level of change to the extreme side of the frequency 
distribution has been nick-named "horse-racing", to indicate that those who win 
or lose will separate themselves ever more clearly from the crowd as time goes 
by.s 
The presence of the phenomenon of horse-racing can be analyzed by linear 
regression of the rate of change in bone density on the initial value of bone 
density (change-in-RCA = a + b x initial-RCA). A positive value of the regres-
sion coefficient (b) will indicate horse-racing; i.e. a high rate of bone loss 
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Figure II 
Schematic representation of the hypothetical relationship between rate of bone 
loss. level of bone density and age. The lines SL-SL' represent slow losers and 
the lines FA-FA' represent fast losers. Before age 50 no loss is present. At age 
50 no relationship is present between rate of loss and level of RCA. As a result 
of horse-racing fast losers (FA') have become over represented at the lower end 
of the frequency distribution of bone density at age 75. 
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in relation to low bone density.* A negative coefficient may be the result of a 
high rate of bone loss at a high level of bone density, but it may also result 
from an important methodological complication of the analysis: regression 
towards the mean. 
The phenomenon of regression towards the mean has been described among 
others by Oldham as a statistical pitfall in longitudinal analyses. 11 The problem 
arises from the presence of a random component in the initial and follow-up 
* Since change-in-RCA has a negative value. a positive value of the 
coefficient (b) in the regression equation is indicative of a less 
negative value of change-in-RCA in relation to high initial bone 
density and a more negative value of change-in-RCA in relation to 
low bone density. To avoid confusion: a positive association is 
indicative of high loss in relation to low initial level. 
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measurements of bone density. A single measurement of bone density can be 
considered as being composed of "true" bone density and measurement erTor. For 
those individual subjects where the measurement error in the initial measure-
ment had been coincidentally high. the follow-up measurement enor will be zero 
on average (assuming that the measurement enor is distributed randomly). Also. 
for those individual cases where the measurement error in the initial measure-
ment had been coincidentally low, the follow-up measurements enor will be 
zero on average. Thus. if "true" bone density remains unchanged, high initial 
values will be related to lower follow-up measurements and low initial values 
will be related to higher follow-up measurements on average. In other words. 
the extreme values of the initial measurements will be closer to the mean at 
follow-up (regression towards the mean). This is because part of the extreme 
values were due to coincidental extreme measurement errors. As a result. the 
rate of bone loss at a high level of bone density would be spmiously over-
estimated and the rate of bone loss at a low level of bone density would be 
spuriously underestimated. A regression analysis of rate of change on initial 
value will result in a regression coefficient that is spuriously negative. or at 
least too low. 
Various statistical techniques have been proposed to adjust for regression 
towards the mean. Oldham suggested regression of the rate of change on the 
mean value of initial and follow-up measurements. 11 Feinleib et al. have 
demonstrated that this technique is equivalent to an analysis of change in 
standard deviation, as described above. 9 They suggested an altemative method 
based on analysis of three or more measurements for each individual. Blomqvist 
et al. suggested a method of adjustment based on an estimation of the magni-
tude of the random component in the measurements. 12 ' 13 The latter approach 
was chosen for the present analysis. In an analysis of simulated data this 
approach resulted in a correct estimation of the regression coefficient, provided 
that the random variance was not of the same magnitude as the total variance 
(CotTection Factor is 1. resulting in division by zero in the calculation of the 
adjusted coefficient: see page 78). This condition was clearly fulfilled in the 
case of bone density measurements (page 82). A disadvantage of the technique 
as described by Blomqvist is that it depends strongly on an exact estimation of 
the random enor. If the enor is underestimated. the regression coefficient may 
76 
remain spuriously negative or too low. If the error is overestimated. a spurious 
conclusion concerning the presence of horse-racing may result. In the present 
analyses the measurement error was used as estimation of the random variance. 
This is a conservative estimate. because a possible random component in the 
measurements clue to repeating a radiograph was not included in the error esti-
mation. Finally. it should be noted that. irrespective of the sign of the coeffi-
cient. a trend between consecutive age groups can be indicative of the presence 
of horse-racing if the coefficient becomes more positive in elderly age groups. 
5.2.2. Relevance of differences in bone loss 
The analytic approaches discussed above were intended for an evaluation of 
the presence of differences in the rate of bone loss between women. A next 
step in the analysis aimed at an evaluation of the contribution of differences in 
the rate of bone loss to the occurrence of osteopenia. This was done by 
predicting the occurrence of osteopenia at follow-up by rate of bone loss or by 
initial level of bone density. The sensitivity and specificity of a predictiort of 
osteopenia were compared for high/low rate of loss and high/low initial bone 
density. 
5.3. Statistics 
In the analyses, subjects who had one or more m1ssmg values for initial or 
follow-up bone density were excluded. For 56 of 855 women who participated in 
the complete follow-up investigation. either the initial or the follow-up radio-
graphs were missing. or could not be measured for technical reasons. Complete 
data were available for 799 women. The mean value and standard deviation of 
initial RCA were similar for the 799 women that were used in the analyses and 
for 302 women who were not investigated. but for whom the baseline radio-
graphs were available. 
Three year moving averages of RCA were used for graphical presentation of 
the cross-sectional relationship between RCA and age. The relationship was 
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quantified by means of linear regression analysis. The frequency distlibutions of 
RCA were plotted in 5-year categories of age. To this encl. data of the initial 
and follow-up investigation were combined; the curves were smoothed by sight. 
The relationship between the rate of loss in RCA and the level of RCA. 
which could be indicative of the presence of consistent fast bone losers (horse-
racing). was evaluated in linear regression analyses. as clesctibed above 
(change-in-RCA= a + b x initial-RCA). Adjustment for regression towards the 
mean was performed as described by Blomqvist et al.: 13 the maximum likelihood 
estimate of the "true" regression coefficient was calculated from the observed 
coefficients. The necessary correction factor (CF) was calculated as the ratio of 
the random valiance and the observed variance of the measurements (for each 
age group). The measurement error of RCA was used as a conservative estima-
tion of the random valiances. The Adjusted Coefficient (AC) was calculated 
from the Observed Coefficient (OC) according to the formula: 
AC=(OC+CF)/(1-CF). The Adjusted Standard Error (ASE) was calculated from the 
Observed Standard Error (OSE) according to the fmmula: 
ASE2/(l +AC)2 = OSE2/(l +OC)2 + (2 x CF2/(l-CF)2)x(IIf+ I!f1). wherefandf1 
Table I 
Mean values and standard deviations (SD) of Relative Cortical Area (RCA) in 
5-year categories of initial age. Data from 799 women; EPOZ (1975-78) and 
follow-up (1985-86). 
EPOZ Follow-up 
Initial Number of RCA-1 SD RCA-2 SD 
Age Persons (mm2 %) (mm2 %) 
45-49 285 81.2 6.4 76.0 6.5 
50-54 204 79.9 7.0 73.3 7.3 
55-59 182 76.5 7.0 69.8 7.8 
60-64 128 72.1 7.7 66.2 8.6 
All 799 78.3 7.6 72.3 8.1 
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were the degrees of freedom for the estimated total and error variance. The 
division of the crude change in RCA by postmenopausal years during follow-up. 
was taken into account by multiplying OC and OSE by this number of years 
prior to the calculation of the adjusted values. and dividing AC and ASE by the 
same number of years after the calculation. 
5.4. Results 
a. Relative Cortical Area: 
The mean values and standard deviations of RCA are presented in 5-year 
categories of initial age in Table I. The mean values of RCA declined with age. 
both cross-sectionally (compare age categories) and longitudinally (compare 
Figure III 
Three year moving averages of Relative Cortical Area (RCA) in relation to age. 
Data from 799 women from an initial (EPOZ: 1975- I 978) and a follow-up (1985-
1 986) investigation. 
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RCA-I to RCA-2). The standard deviation of RCA showed a slight increase both 
from one age category to the other and over the period of follow-up. 
The cross-sectional relationship of RCA and age is shown graphically in 
Figure III. In linear regression analysis of the cross-sectional data the diffe-
rence in RCA for women over 50 years of age was -0.80 mm2 % per year of age 
(p<O.OOI) for the initial investigation ancl-0.68 mm2 % per year of age (p<O.OOI) 
at follow-up. Before age 50. the difference in RCA was -0.06 mm2 % per year of 
age. which was not significantly different from zero. In a similar analysis using 
years since menopause instead of age the decline in RCA for the premenopausal 
2 
women was -0.02 mm %/yr. 
Smoothed drawings of the frequency distlibution of RCA are shown in 5-year 
categories of age in Figure IV. The cross-sectional difference in RCA between 
age categories was reflected in a shift of the entire range of the distribution 
towards the lower values. If an arbitrary cutoff level for osteopenia was chosen 
at 70 mm2 %. the prevalence of osteopenia increased from 5 per cent among the 
women aged 45 to 49 years. up to 68 per cent among the women aged 70 to 76. 
Table II 
Mean values. standard deviations (SD) and 90 per cent range of annual rate of 
change-in-RCA as an absolute value and as a percentage of the initial value of 
bone density (%-change) in 5 year categories of initial age. Data from 799 
women. (EPOZ Follow-up Osteoporosis). 
Percentiles 
Initial Number of Change-in-RCA SD 5th 95th %-Change 
Age persons (mm2 %/yr) (%) 
45-49 285 -0.91 0.97 -3.09 +0.16 -1.1 
50-54 204 -0.84 0.63 -1.89 -0.10 -1.0 
55-59 182 -0.76 0.50 -1.63 -0.10 -1.0 
60-64 128 -0.65 0.46 -1.38 -0.10 -0.9 
All 799 -0.82 0.73 -2.16 0.00 -1.0 
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Figure IV 
Frequency distribution of Relative 
age. Data from 799 women from 
(1985-86) investigation were combined. 
Cortical Area (RCA) in 5-year categories of 
an initial (EPOZ: 1975-78) and a follow-up 
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b. Loss of Relative Cortical Area: 
The mean annual rate of change-in-RCA. calculated from the longitudinal data 
is pre~ented in Table II. The average change-in-RCA was -0.82 mm2 % per year. 
which is -1.0 per cent of the mean initial RCA. The rate of change became less 
negative in relation to age. from -0.92 mm2% or -I. I per cent per year for the 
women initially aged 45 to 49 years to -0.65 mm2% or -0.9 per cent per year 
for the women initially aged 60 to 64 years. The absolute age related decline in 
the rate of loss was statistically significant (p<0.005) in linear regression ana-
lysis. If the rate of loss was expressed as percentages of the initial value of 
RCA. the decline was not significant (p<0.12). 
Bone loss was present in 95 per cent or more of the women over 50 years of 
age. The total variance in change-in-RCA was 0.53 (mm2 % )2 ; the estimated error 
variance was 0.15 (mm2%)2; thus an estimate of the "true" variance was 0.38 
(mm2 % )2 . or 72 per cent of the total variance. 
Table III 
Adjusted regression coefficients (b) of linear regression analysis of annual rate 
of change-in-RCA on initial level of RCA. for 799 women in 5-year categories 
of initial age. Change-in-RCA was expressed as absolute change and as percen-
tage-change of the initial value. Adjustment for regression towards the mean 
according to Blomqvist. Standard errors (SE) in parentheses. (EPOZ Follow-up 
Osteoporosis). 
Initial Number of Absolute change Percentage-change 
* Age persons b (SE) b * (SE) 
45-49 285 -0.030** (0.010) -0.022 (0.014) 
50-54 204 -0.012 (0.008) -0.001 (0.010) 
55-59 182 +0.006 (0.007) +0.021 ** (0.009) 
60-64 128 +0.010 (0.007) +0.030 ** (0.009) 
All 799 -0.012 ** (0.004) -0.001 (0.006) 
* Slope of change-in-RCA on initial RCA 
** p<0.05 
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c. Horse-racing: 
The adjusted coefficients (b) and standard errors of the regression analyses of 
change-in-RCA on initial RCA are presented in Table III. The analyses were 
performed separately for change-in-RCA as an absolute value and for change-in-
RCA as a percentage of the initial value. For the total group. absolute change-
in-RCA was negatively related to the level of RCA and percentage-change was 
unrelated to level of RCA. The relationship was dependent on age. In 5-year 
age categodes the negative relationship was strongest for the younger women. 
In elderly women the relationship became positive. For percentage-change a 
more positive relationship was present in all age categodes. Both for absolute 
and for percentage-change the coefficients increased consistently from the 
younger towards the older age categ01ies, which is indicative for horse-racing. 
d. Prediction of osteopenia at follow-up: 
At the time of the initial investigation. RCA was below the arbitrary 
Table IV 
Cross table of A). Rate of bone loss during a 9-year follow-up period and 
presence of osteopenia at follow-up (1985-86) and B). Initial bone density 
(1975-78) and presence of osteopenia at follow-up (1985-86) for 799 middle aged 
women. (EPOZ Follow-up Osteoporosis). 
Osteopenia at follow-up (RCA < 70 mm2 %) 
A. No Yes Total 
Slow Losers (~ I %/yr) 343 105 448 
Fast losers ( > 1 %/yr) 186 165 351 
Total 529 270 799 
B. No Yes Total 
Initial RCA > 
0 77 mm-% 418 32 450 
Initial RCA 77-70 mm2 % 110 137 247 
Initial RCA < 70 mm2 % I 101 102 
Total 529 270 799 
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70 mm2 % limit for osteopenia in 12.8 percent of the women. At follow-up this 
percentage had increased to 33.8 %. The relationship between rate of loss and 
occmTence of osteopenia is presented in Table IV-A for an arbitrary cutoff 
level for rate of loss at I per cent per year. If the presence of osteopenia at 
follow-up was predicted by considering a rate of bone loss above l per cent per 
year as a positive "test". the sensitivity and specificity of the prediction were 
0.61 and 0.65 respectively. The relationship between initial level of bone density 
and presence of osteopenia at follow-up is presentee! in Table IV-B for an 
arbitrary cutoff level for initial bone density at 77 mm2 %. If the presence of 
osteopenia at follow-up was predicted by consideling a low initial bone density. 
below 77 mm2 %. as a positive "test". the sensitivity and specificity of the 
prediction were 0.88 and 0.79 respectively. 
5.5. Comment 
The results of the analyses can be summarised as follows. Bone loss was present 
in more than 95 per cent of the women initially aged 50 years and over. On 
average. the rate of bone loss was 1 per cent of the initial bone density per 
year. The rate of bone loss was not similar for all women. but the differences 
in rate of bone loss that were present contributed relatively little to the 
occurrence of osteopenia. 
5.5.1. Differences in bone loss 
The presence of differences in the rate of bone loss between individuals was 
evaluated in three ways. Firstly. the standard deviations of bone density were 
compared cross-sectionally between consecutive age groups and longitudinally 
within each age group over the period of follow-up. Secondly. actual differences 
in the rate of bone loss as measured longitudinally were evaluated; and thirdly 
the rate of bone loss was related to the level of bone density. 
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1. Comparison of the standard deviation of bone density in 5-year age groups 
revealed a small but consistent increase from one age group to the other. Also. 
an increase in the standard deviation was present over the period of follow-up. 
This may be interpreted as an indication that individuals were losing bone at 
different rates. Alternatively. cross-sectional differences in the standard 
deviation may be explained from historical variation in the presence of bone 
losing influences ( cohmt-effect). Some of the longitudinal differences in the 
standard deviation may have occurred as a result of variation in the period of 
follow-up. 
2. Differences in the rate of bone loss were present between individuals in the 
longitudinal measurements. Theoretically. these differences may originate from 
"real" biological differences or from differences due to measurement error. In 
the present investigation. the measurement error was insufficient to explain the 
variation in the rate of bone loss between individuals. This again suggests "real" 
differences in the rate of bone loss between individuals. It should be noted, 
however. that the range of the differences may be considerably less than the 
range indicated in Table III. Extreme values are pat1icularly likely to be 
affected by measurement errors. 
5.5.2. Horse-racing 
The long term impact of differences in the rate of bone loss was evaluated by 
relating the rate of change-in-RCA to the level of bone density. If a high rate 
of bone loss does acid to the occurrence of osteopenia. it may be anticipated 
that in clue time. if bone loss continues at a high rate. it will become fastest 
among the women with a low bone mass (horse-racing). In a regression analysis 
of the rate of change-in-RCA on level of bone density. a positive regression 
coefficient will indicate horse-racing (high loss related to low level). A negative 
coefficient may indicate that bone loss proceeds fastest in individuals with a 
high bone density. or it may indicate regression towards the mean. 
In the present data a negative relationship was present between the absolute 
rate of change-in-RCA and the initial level of RCA. In consecutive 5-year 
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categories of initial age the coefficient was more positive in each next age 
group. The latter observation is indicative of horse-racing. A similar relationship 
has been found previously for change in blood pressure. 10 The interpretation of 
these results is complicated, because it can not be excluded that the negative 
sign of the coefficients are the result of an underestimation of the random 
error component in the measurements, whith would result in insufficient 
adjustment for regression towards the mean. If this possibility is left aside, the 
most likely explanation of the results might be that in the beginning of the 
process of bone loss, just after the age of 50 years. rate of change-in-RCA is 
negatively related to bone density (Figure I; Model II). However, at each level 
of bone density, some individuals are losing bone tissue more rapidly than 
others and horse-racing does occur (Figure II). As a consequence. the initial 
proportional relationship between bone loss and bone density (high loss in 
relation to high level) becomes overshadowed by the subgroup of fast losers 
shifting down in the distribution of bone density. This hypothetical model of a 
Figure V 
Hypothetical model of a combination of proportional bone loss (high loss in 
relation to high level) and horse-racing. The lines SL-SL' represent slow losers; 
the lines FA-FA' represent fast losers. 
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combination of propmiional bone loss and horse-racing is represented graphi-
cally in Figure V. The model is only schematic. since in a truly proportional 
model of bone loss. the lines ought to be curved. Physiologically this inter-
pretation can be supported if it is assumed that bone loss is a result of a 
disequilibrium between bone formation and bone resorption. as it occurs at the 
metabolic smface of the bone tissue. The absolute amount of bone that is lost 
will depend on the magnitude of the disequilibrium and on the size of the 
metabolic smface. The proportional component of the bone loss (Figure 1: 
Model II). as manifested by the negative association between change-in-RCA and 
level of RCA in the younger age groups. can be considered as the influence of 
the size of the metabolic surface. The horse-racing component as manifested in 
the negative relationship between change-in-RCA and level of RCA being more 
positive in every next 5-year category of initial age, could be considered the 
result of a different magnitude of the disequilibrium between bone loss and 
bone formation. The influence of the size of the metabolic smface was (more or 
less) controlled in the analysis of percentage-change on initial bone density. As 
expected the coefficients were more positive (Table III). 
An interesting feature of the model that is presented in Figure V is that the 
standard deviation remains relatively constant over time, despite the obvious 
differences in the rate of bone loss between individuals. In fact. the model 
illustrates that an evaluation of the presence of differences in the rate of bone 
loss between individuals on the basis of age related changes in the standard 
deviations may be of limited value. The model may explain some of the conflic-
ting statements in the literature concerning the absence or presence of fast 
losers. 
5.5.3. Relevance of differences in the rate of loss 
Considering these results. we may wonder whether the occurrence of a fast 
rate of loss among some individuals contributes practically to the occurrence of 
osteopenia in the population. This question has become of clinical importance 
recently, since Chtistiansen et a!. reported about a simple and sensitive test to 
select women with more than average bone loss. without measuring bone 
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density. They suggested the use of the test for selection of women for prophy-
lactic oestrogen therapy. 14 In the present data initial bone density was a better 
predictor of osteopenia at follow-up than rate of bone loss. Apparently. the 
differences in the rate of loss between individuals were not sufficiently large to 
contribute importantly to the occurrence of osteopenia over a nine year period. 
The range between an initial high and low bone density is of such magnitude. 
that it may be doubted whether relative small differences in the rate of loss 
between individuals will contribute much more to the occurrence of osteopenia 
over a longer time period. In a clinical sense, the idea of Newton-John that 
bone density at old age is predominantly determined by bone density at a 
younger age may still be valid. 
5.6. Summary of the chapter 
Age related bone loss and differences in the rate of bone loss. were evaluated 
in a longitudinal population based study among 799 women initially aged 45 to 
64 years. Radiographs of the hands were made twice, over an average follow-up 
period of nine years. The Relative Cortical Area (RCA) of the metacarpals, and 
the annual rate of loss of RCA were determined. 
Bone loss started around the age of 50 years, presumably after the meno-
pause. The average annual rate of Joss was approximately 1 per cent of the 
initial value. If osteopenia was defmed as a level of RCA below the fifth 
percentile of women aged 45 to 49 years, the prevalence of osteopenia increased 
from 5% (by definition) for women aged 45 to 49 years. up to 68 percent for 
women aged 70 to 76. 
Bone loss was present in more than 95 per cent of women over 50 years of 
age. The rate of loss was not similar for each individual. The data indicated the 
presence of a consistent subgroup of fast bone losers. The occurrence of 
osteopenia at the time of follow-up. however. was more accurately predicted 
from initial bone density than from differences in the rate of loss. The 
occuiTence of osteopenia was more strongly determined by bone density at a 
young age than by differences in the rate of bone loss. 
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Chapter 6 
Sex Hormone Binding Globulin in postmenopausal women: a predictor of 
osteoporosis superior to endogenous oestrogens 
6.1. Introduction 
In postmenopausal women oestrogens are known to be related to bone loss 
and risk of fractures. 1 Postmenopausal bone loss can be prevented by oestrogen 
substitution therapl·3, and women who have had such therapy suffer less 
fractures of the ve1tebrae.4 forearm5 and femoral neck.5·6 The importance of 
endogenous oestrogen activity in preserving bone density after the menopause is 
illustrated from the loss of bone tissue in relation to oophorectom/ and from 
the well documented positive correlation between body mass and bone density. 8 
After the menopause. when the ovarian oestrogen production has ceased, body 
mass becomes the main determinant of endogenous oestrogen activity. 9 Andro-
stenedione produced in the adrenal glands may be converted in peripheral 
tissues to oestrone. which in turn may be further conveiied to the more potent 
oestradiol. 10 
In two recent investigations forearm mineral density and forearm mineral Joss 
were found to be related directly to postmenopausal serum oestrone and oestra-
diol concentrations. 11 ·12 In the present investigation the role of (lack of) endo-
genous oestrogen activity as a contributing factor in the etiology of postmeno-
pausal osteoporosis was elaborated in further detail. In a population based 
investigation among 746 postmenopausal women aged 53 to 76 years. body mass. 
serum oestradiol. oestrone. androstenedione and sex hormone binding globulin 
(SHBG) levels. were investigated cross-sectionally in relation to metacarpal bone 
density and retrospectively in relation to annual rate of metacarpal bone loss 
(change-in-RCA; chapter 3. page 43) and occurrence of fractures. The size of 
the study population allowed an estimation of the influence of each of these 
variables while adjusting for correlation to the others. 
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6.2. Statistics 
In the statistical analyses. subjects who had one or more missing values for 
any of the study variables were excluded. Complete data were available for 763 
women. of whom 17 were excluded from the analyses. because they had pre-
menopausal oestradiol levels above I 00 pmol/1. The mean values. standard 
deviations and 90 per cent ranges of the study variables are summarised in 
table I. The frequency distributions of some of the variables. especially for 
oestradiol. were considerably skewed. The results of the analyses were not 
essentially different if the distributions were normalised by logistic transfor-
mation. 
Univariate and multivariate linear regression analyses were used to evaluate 
the relationship between either RCA at follow-up or change-in-RCA and the 
study variables (hormone levels. body mass and age at follow-up). Multivariate 
analyses were used to adjust for interdependency between the study variables. 
Table I 
Mean values. standard deviations (S.D.) and 90 per cent ranges of study varia-
bles in 746 Dutch postmenopausal women aged 53 to 76 years. (EPOZ Follow-up 
Osteoporosis). 
Percentiles 
Mean S.D. 5th 95th 
Age at follow-up (years) 62.3 5.6 54.7 72.2 
RCA at follow-up (mm2 %) 72.2 8.0 57 84 
Change-in-RCA (mm2 %/yr) -0.82 0.69 -2.16 0.00 
SHBG (nmol/1) 78.4 49.3 16.7 158.3 
Oestradiol (pmol/1) 28.2 20.6 5 69 
Oestrone (pmol/1) 140.9 52.7 69 238 
Androstenedione (nmol/1) 3.5 1.9 1.2 7.1 
Body mass (kg/m2 ) 26.3 3.9 20.7 32.9 
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To facilitate mutual comparisons within the study population. regression 
coefficients were standardized by multiplication with the standard deviation of 
the variable concerned. These standard deviations. as estimated from a sample 
of the general population were considered as the natural range of the variables. 
For comparisons to different populations it may be wise to check for the 
similarity of standard deviations. 13 The value of these standardized coefficients 
represents the mean difference in the dependent variable (RCA or change-in-
RCA) with l standard deviation difference in the independent variable (e.g. 
hormone levels). For example. a difference in serum SHBG level of 49.3 nmol/l 
(l standard deviation: Table I) corresponds to a mean difference in RCA of-
1.85 mm2 % (standardized regression coefficient: Table II). 
A t-test was used to evaluate the differences in the mean values of the study 
variables for the women who had no fractures. those who had type I osteo-
porotic fractures (forearm or ve1iebral fractures) and those who had other. 
non-osteoporotic fractures. 
Table II 
Standardized regression coefficients of univariate and multivariate analyses of 
study variables on RCA at follow-up in 746 Dutch postmenopausal women aged 
53 to 76 years. Standard errors in parentheses. (EPOZ Follow-up Osteoporosis). 
Univariate p < Multivariate p < 
Age at follow-up -3.64 (±0.26) 0.001 -3.57 (±0.25) 0.001 
SHBG -1.85 (±0.29) 0.001 -1.15 (±0.26) 0.001 
Oestradiol 1.14 (±0.29) 0.001 0.82 (±0.28) 0.005 
Oestrone 1.11 (±0.29) 0.001 0.44 (±0.31) ns 
Androstenedione 0.53 (±0.29) ns 0.0 l ( ± 0.28) ns 
Body mass 0.81 (±0.29) 0.001 0.65 (±0.28) 0.05 
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6.3. Results 
The standardized regression coefficients of the analyses for Relative Cortical 
Area (RCA) are presented in Table II. In the univariate analyses. RCA was 
positively related to body mass. serum oestrone. oestradiol and androstenedione 
and negatively to age and serum SHBG. Ail relationships were statisticaiiy 
significant. with the exception of that for androstenedione. In the multivariate 
analysis the relationship was no longer significant for serum oestrone and the 
regression coefficient for androstenedione decreased virtually to zero. Apart 
from age. the standardized regression coefficient for SHBG was largest (as an 
absolute value). foiiowecl by oestradiol anc\ body mass. 
The standardized regression coefficients of the analyses for the annual rate 
of change-in-RCA are presentee\ in Table III. In the univariate analyses. 
change-in-RCA was less negative at a high body mass. serum oestrone. oestra-
diol. androstenedione and age. Change-in-RCA was more negative at a high 
serum SHBG. Again. ail relationships were statisticaiiy significant with the 
exception of that for androstenedione. In the multivariate analysis the regres-
sion coefficients for age ancl SHBG remained statistically significant. If the rate 
of bone loss was expressed as percentage of the initial value (standardization 
Table III 
Standardized regression coefficients of univariate and multivariate analyses of 
study variables on change-in-RCA in 746 Dutch postmenopausal women aged 53 
to 76 years. Standard errors in parenthesis. (EPOZ Follow-up Osteoporosis). 
Univariate p < Multivariate p < 
Age at follow-up 0.107 (±0.025) 0.001 0.113 (±0.025) 0.001 
SHBG -0.092 (±0.025) 0.001 -0.090 ( ±0.026) 0.005 
Oestradiol 0.077 (±0.025) 0.005 0.047 (±0.027) ns 
Oestrone 0.070 (±0.025) 0.01 0.042 (±0.030) ns 
Androstenedione 0.019 (±0.025) ns -0.018 (±0.028) ns 
Body mass 0.068 (±0.025) 0.01 0.013 (±0.027) ns 
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Table IV 
Mean value of study variables for subjects with and without fractures in 746 
Dutch postmenopausal women aged 53 to 76 years. Standard errors in paren-
theses. (EPOZ Follow-up Osteoporosis). 
Total group 
Osteop. frac. t-test 
(n=62) 
Age at follow-up 64.7 ( ±0. 7) 
RCA at follow-up 69.2 (± 1.0) 
* 
* 
no frac. 
(n=620) 
61.8(±0.2) 
72.5(±0.3) 
Change-in-RCA 
SHBG 
-0.76 (±0.08) ns -0.83(±0.03) 
87.3 (±6.3) ns 77.9(±2.0) 
Oestradiol 29.4 (±2.6) ns 28.2(±0.8) 
Oestrone 151.8 (±6.4) ns 
Androstenedione 3.8 (±0.2) ns 
Body mass 27.0 (±0.5) ns 
Age ~ 65 years 
Osteop. frac. t-test 
(n=31) 
Age at follow-up 69.5 (±0.5) ns 
RCA at follow-up 
Change-in-RCA 
SHBG 
66.8 (±1.4) 
-0.71 (±0.07) 
102.9 (± 10.0) 
ns 
ns 
* 
140.6(±2.1) 
3.5(±0.1) 
26.2(±0.2) 
no frac. 
(n=191) 
68.9 (±0.2) 
68.0 (±0.6) 
-0.68 (±0.03) 
81.9 (±3.8) 
Oestradiol 34.7 (±4.2) ns 29.6 (± 1.5) 
Oestrone 153.9 (±6.6) ns 142.4 (±4.2) 
Androstenedione 3.9 (±0.3) ns 3.6 (±0.2) 
Body mass 26.1 (±0.7) ns 26.4 (±0.2) 
* p<0.05 
t -test 
* 
ns 
ns 
ns 
ns 
ns 
* 
ns 
t-test 
ns 
ns 
ns 
ns 
ns 
ns 
* 
* 
other frac. 
(n=64) 
63.5 (±0.8) 
71.3 (±0.8) 
-0.81 (±0.08) 
75.0 (±5.9) 
27.0 (±2.5) 
133.5 
3.0 
27.0 
(±6.4) 
(±0.2) 
(±0.5) 
other frac. 
(n=27) 
69.8 (±0.6) 
67.3 (±1.3) 
-0.79 (±0.08) 
79.5 (± 12.1) 
32.9 (±4.8) 
133.0 (±11.3) 
3.0 (±0.2) 
27.6 (±0.5) 
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for metabolic stnface; chapter 5. page 87) the relationships were essentially 
similar. 
The mean values of the study variables for fracture patients and controls are 
presented in Table IV. Statistically significant differences were found for age. 
RCA and serum androstenedione (Table IV-upper panel). Women who had one or 
more fractures in the previous nine years were older than women without 
fractures. RCA was lower for women with type I osteoporotic fractures and 
androstenedione was lower for women with non-osteoporotic fractures. In the 
subgroup of elderly women. aged 65 years and older. statistically significant 
differences were found for serum SHBG. body mass and serum androstenedione 
(Table IV-lower panel). SHBG levels were higher for women with type I 
osteoporotic fractures. Body mass was higher and serum androstenedione lower 
for women with other fractures. The differences between cases and controls 
were not substantially influenced by multivariate adjustments. 
6.4. Comment 
a. Bone density and bone loss: 
The influence of endogenous oestrogen activity on bone density and bone loss 
has been found in several studies. Murakami et al. have demonstrated a positive 
correlation between serum oestradiol and forearm mineral density in postmeno-
pausal women14 and Cauley et al. have found a similar relationship for semm 
oestrone. 11 Riis et al. have demonstrated lower levels of both serum oestradiol 
and oestrone in postmenopausal women characterized as rapid bone losers as 
compared to slow bone losers. 12 None of the previous studies have investigated 
the independent influences of oestrone. oestradiol. SHBG or body mass in 
relation to bone mass or bone loss. 
In the present study bone density was positively related to the serum 
concentration of oestradiol and negatively to the concentration of SHBG. The 
negative influence of SHBG on bone density was confirmed by its relation to 
the rate of bone loss. The serum concentration of oestrone was not an impor-
tant dete1minant of bone density or bone loss. The results of the multivariate 
analyses demonstrated that the influence of oestrone as a single variable was 
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explained by its correlation to the other variables. Oestrone was especially 
correlated to oestradiol (r=0.40) and body mass (r=0.34). The serum concen-
tration of androstenedione was unrelated to either bone density or bone loss. 
In the multivariate analysis, body mass was positively related to bone density. 
but not to bone loss. The relationship between body mass as a single variable 
and bone loss. was explained by the correlation of body mass to the other 
variables. Body mass was especially correlated to oestrone (r=0.34). oestradiol 
(r=0.23) and SHBG (r=-0.28). Apparently. the relationship between body mass and 
bone loss was mediated by the positive association of body mass with oestrogen 
level and the negative association of body mass with SHBG. The latter asso-
ciation has been previously described by de Moor et al .. 15 The persistence of an 
association between body mass and bone density. in the multivariate analysis 
may suggest an independent premenopausal positive influence of body mass on 
(peak) bone density. 
b. Fractures: 
Low bone density or high rate of bone loss are no pathologic conditions as 
long as the skeleton remains intact. The pathology of these conditions lies in 
the increased likelihood of fractures. The role of endogenous sex steroid 
activity in relation to fracture risk has been investigated in several small case-
control studies. For women with vertebral fractures normal. increased and 
decreased levels of oestrogens have been found and levels of SHBG, andro-
d. al . h . . f d' 16 17 18 19 20 stene wne or testosterone were norm m t e maJonty o stu tes. ' ' · · 
For women with femoral neck fractures Davidson et al. demonstrated increased 
levels of SHBG. decreased levels of free oestradiol and testosterone and normal 
levels of androstenedione and oestrone. 21 It must be noted that in most studies 
the subjects with vetiebral fractures were roughly l 0 years younger than those 
with femoral neck fractures. This is important because bone loss is a process 
which proceeds relatively slow. It will take a considerable petiod of time before 
fast bone losers differentiate themselves from slow bone losers in terms of an 
increased fracture risk. As a consequence. a contrast in sex hormone activity 
between fracture cases and healthy controls is most likely to be found in 
elderly women. 
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The present investigation was based on a large unselected sample of post-
menopausal women. No differences were found between fracture cases and 
controls for serum levels of oestrone and oestradiol. For androstenedione serum 
levels were decreased in women with other than type I osteoporotic fractures. 
This relationship may be coincidental. since no relationships were found between 
androstenedione levels and bone density or bone loss. For SHBG no differences 
were found for the total study population. but an increased level of SHBG was 
demonstrated for the subgroup of elderly women with type I osteoporotic 
fractures. This suggests an increased risk of these fractures after an extended 
period of exposure to high levels of SHBG. 
In conclusion. the role of endogenous oestrogens was investigated in relation 
to the level of bone density. the rate of bone loss and the risk of fractures in 
a large population based study. The level of serum SHBG was found to be a 
stronger detenninant of bone density and bone loss than either serum oestradiol 
or oestrone levels and among these. SHBG was the only factor which was also 
related to fracture risk. Most likely. these findings should be explained from a 
dominant negative influence of SHBG on free (active) oestradiol and possibly on 
free (active) testosterone. Probably. the variance in free oestradiol in postmeno-
pausal women is determined more strongly by the variance in SHBG than by the 
variance in total oestradiol. The results support the hypothesis that endogenous 
oestrogen activity in general. and serum SHBG in particular. may play a 
significant role in the etiology of postmenopausal osteoporosis. 
6.5. Summary of the chapter 
To quantify the role of endogenous oestrogen activity in osteoporosis body 
mass. Relative Metacarpal Cmtical Area (RCA) serum oestrone. oestradiol. 
androstenedione. and Sex Hormone Binding Globulin (SHBG) were measured in 
746 postmenopausal women aged 53 to 76 years. The occurrence of fractures and 
the rate of loss of RCA (change-in-RCA) were deterrnined over the previous 
nine years. 
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Both RCA and change-in-RCA were significantly related to body mass. serum 
oestrone. oestradiol. and SHBG. The influence of the first three variables ap-
peared to be bone preserving. whereas the latter appeared to be bone wasting. 
Serum oestradiol. SHBG and body mass proved to have an independent relation-
ship with RCA in a multivariate regression analysis. The relationship to 
change-in-RCA was statistically independent for serum SHBG only. Serum andro-
stenedione was unrelated to either RCA or change-in-RCA. 
In the total study population. body mass. serum oestrone. oestradiol and SHBG 
were unrelated to the occurrence of fractures. Androstenedione levels were 
lower for women with non-osteoporotic fractures. as compared to controls 
without fractures. In the subgroup of 249 elderly women. aged 65 to 76 years. 
SHBG levels were significantly higher for women with type I osteoporotic 
fractures as compared to controls. 
These results suggest a substantial bone wasting influence of SHBG in post-
menopausal women. possibly resulting in an increased risk of type I osteoporotic 
fractures in elderly women. 
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Chapter 7 
A reflection on the methods and some recommendations 
7.1. Introduction 
The investigation that is the subject of this thesis can be characterised as a 
longitudinal population based investigation, that was intended to evaluate the 
accuracy of fracture prediction on the basis of known risk factors of osteo-
porosis. In addition. the pattern of metacarpal bone loss in middle-aged women 
and the possible role of endogenous oestrogen activity in the pathogenesis of 
osteoporosis were investigated. From the point of view of epidemiologic 
methodology. chapter four is an example of a clinical prediction study for the 
evaluation of the efficiency of one particular approach of selecting patients for 
fracture prevention programmes. Chapter five is an example of a mathematical 
analysis of the homogeneity of a process of change within a population. The 
existence of differences in the rate of bone loss between individuals and the 
relevance of these differences for the occurrence of osteopenia were evaluated. 
Chapter six is an example of an evaluation of the relationship between a 
potential pathogenetic factor (endogenous oestrogen activity) and the occurrence 
of a disease (osteoporosis). 
The results of the investigation can be summarised as follows: 
a. Prediction of fractures (chapter 4): 
1) Fractures occurred frequently in middle-aged women and the risk of 
fractures increased with age. 
2) Fractures of the forea1m and of the veiiebral bodies (Type I osteoporotic 
fractures) were most frequent. next to fractures of the small bones of 
hands and feet. 
3) The maj01ity of the veiiebral fractures had been undiagnosed before the 
investigation. presumably because the majority of these fractures were 
asymptomatic. 
4) Prediction of the occuiTence of fractures on the basis of risk factors of 
osteoporosis was inaccurate. 
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b. Pattem of metacarpal bone loss (chapter 5): 
5) Bone loss occurred in more than 95 per cent of the women over 50 years 
of age. 
6) The rate of bone loss was approximately l per cent of the initial bone 
density per year. 
7) The rate of bone loss was not similar for all women; in some the Joss was 
consistently more rapid than in others. 
8) At a younger age the rate of bone loss was fastest for women who had a 
high bone density: at older age the rate of bone loss was fastest for 
women who had a low bone density. 
9) Differences in the rate of bone loss between individuals were of limited 
value for the prediction of metacarpal osteopenia at follow-up. The level 
of initial bone density was more inf01mative. 
c. Endogenous oestrogen activity (chapter 6): 
I 0) Body mass (Quetelet-index). serum oestrone. serum oestradiol and sex 
hormone binding globulin (SHBG) levels were all related to osteoporosis; 
the serum androstenedione level was not. 
11) The relationship between body mass and osteoporosis was in part explained 
from the relationship between body mass and endogenous oestrogen 
activity. An independent relationship of low body mass to low bone density 
remained unexplained. 
12) The relationship to osteoporosis was stronger for serum oestradiol than for 
oestrone and it was strongest for SHBG. 
13) As an independent factor (i.e. standardized for correlation to the other 
factors) a high level of SHBG was related to a low bone density. a high 
rate of bone loss and an increased risk of fractures. A low level of 
oestradiol was related to a low bone density. 
In organizing the investigation. many considerations were made concerning the 
study design. the inf01mation to be collected. the procedure of data collection. 
the statistical analyses and the presentation of the data. Some of the consi-
derations concerning the study design and the choice of the three major 
analyses will be discussed here. 
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7.2. study design 
The follow-up investigation as it actually took place was the result of a 
development of ideas that began long before the field work sta1ted. In the 
beginning there was a basic idea: with the 1975-78 EPOZ-survey for baseline 
data. inf01mation concerning incident fractures that occurred after this initial 
survey was to be collected in a mailed questionnaire among the middle aged 
women. This information might have been sufficient to answer the initial 
question concerning the clinical value of risk factors of osteoporosis for the 
prediction of fractures. The most important characteristic of this approach was 
the forward directionality of the study design with a long period of follow-up 
among a large group of middle aged women from the general population. Given 
the potentials of such a design, it was judged to be useful to collect informa-
tion on additional variables as well. It was decided to include follow-up 
radiographs of the hands for the purpose of a longitudinal evaluation of bone 
loss. This was an important step in the development of the investigation. 
because it implied that the respondents had to visit the EPOZ-research centre 
in Zoetermeer. A pure administrative follow-up was no longer possible. A next 
step in the development of the investigation was the inclusion of a radiograph 
of the lumbar spine to detect newly occurring (asymptomatic) fractures of the 
vertebral bodies. Also. serum samples were included to create the possibility of 
investigating potential biochemical factors in relation to observed bone loss. 
Finally. for further items to be included in the follow-up investigation. a 
balance was made between the potential interest of the variable versus the 
practical consequences of inclusion. For example. a food questionnaire, several 
antropometric measurements and measurement of blood pressure were included in 
the design. For practical reasons. the collection of data concerning physical 
activity had to be limited to a simple questionnaire only. 
In the final design a questionnaire and a request to visit the research 
centre were sent to all women who were 45 to 64 years of age at the time of 
the initial EPOZ-survey. If the request remained unanswered. the women were 
approached by telephone and invited again. In this way. at least a fracture 
history could be obtained from the women who refused fwiher participation. 
The women who were not reached at all in a first round were contacted in a 
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similar fashion in a second round after addresses had been checked. 
The complete investigation consisted of: I). A questionnaire, for which the 
information was checked in a physician interview (appendix). Additional ques-
tions concerning a history of starvation during world war II and dming the 
economic crisis of the thirties were asked during the interview. 2). A standar-
dized food questionnaire concerning the consumption of Calcium and vitamin D. 
3). Various antropometric measurements. including body height and weight. arm 
span width. diameter of the knees at the level of the femoral epicondyles and 
skinfold thickness at three sites. 4 ). Blood pressure measurements. 5). Radio-
graphs of the hands and of lumbar spine: for the first special precautions were 
made to allow radiographic densitometry. 1 6). Serum and plasma samples. For 
each individual several samples were taken. Part of the samples were frozen for 
future use and part of the samples were used for biochemical measurements. 
including oestrone, oestradiol. androstenedione. sex hormone binding globulin 
(SHBG). LH. FSH. total PTH (including fragments). intact PTH and SMA-12 
measurements of calcium. phosphate. alkaline phosphatase. total globulin. 
albumin. creatinine. bilirubin, sodium. potassium, chloride, SOOT and SGPT. For 
the selection of women who had type I osteoporotic fractures and for a control 
group. the serum concentration of 25-0H-cholecalciferol (25-0H-Vitamin D) was 
measured. 
As a consequence of the divergent approach that was used in the collection 
of the data, a large data set was available for fmiher analyses after the field 
work was ·finished. In the analyses of the data a convergent approach was 
chosen. struiing from the questions to be answered. The first questions to be 
answered were those that were formulated before the actual investigation 
started (chapter 4 and 5). but many more potential questions could be addres-
sed. In this thesis it was chosen to further explore the relationship between 
endogenous oestrogen activity and the occurrence of osteoporosis. The choice 
was paiily based on the observation from the literature on the subject. \Vhich 
demonstrated that postmenopausal oestrogen substitution therapy is the most 
promising and effective intervention for prevention of osteoporosis. It was also 
based on positive results from preliminary analyses and in this respect the 
choice to further analyze this relationship is an example of research being 
biased towards positive results. 
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Besides the relationships that were evaluated in this thesis. the data-set 
offers a multitude of opportunities for further analyses. Some of these poten-
tials have already paid off 2 ' 3 ' 4 ' 5 and results from various fmiher analyses are 
to be expected. (For example: relationship between parameters of calcium 
metabolism and occurrence of osteoporosis; endogenous oestrogen activity and 
bone density as measured with SPA. DPA and QCT; serum concentration of FSH. 
LH and inactive LH-fragments in relation to deficient oestrogen stimulation of 
the hypophysis; biochemical indicators of atherosclerosis; psychological factor as 
measured in EPOZ as a predictor of medical consumption at follow-up). 
7.3. Prediction of fractures 
In the first analysis an evaluation was made of the clinical efficiency of using 
inf01mation about risk factors of osteoporosis for prediction of fractures. This 
evaluation constituted the main reason for conducting the investigation. The 
study design. statistical analysis and presentation of results were all tailored 
towards this goal. The study population of middle aged women from the general 
population was chosen, because this might be an important target population for 
fracture prevention programmes. 6 Baseline information about risk factors was 
related prospectively to fracture occurrence over a relative long period of 
follow-up; a strategy which is optimal to give insight in the potential efficiency 
of fracture prevention programmes if selection for participation were based on 
risk factor information. Follow-up information was collected about the occur-
rence of all fractures. including fractures of the vertebral bodies (which are 
often asymptomatic). 
The statistical analysis was chosen to obtain maximum predictive power from 
the data. The stepwise logistic regression procedure was used as a discriminant 
analysis for optimal separation of fracture patients and nmmals. The possibility 
of overestimating the strength of the relationship between presence of risk fac-
tors and occurrence of fractures was taken for granted. 
In the presentation of the results. the strength of the prediction was 
expressed in te1ms of sensitivity and specificity. as is usual in clinical practice. 
In addition. these measures have a practical application in Bayesian medical 
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decision making. 7 
The choices that were made in the study design and analysis unavoidably 
brought along certain limitations. The investigation was made possible by the 
availability of the EPOZ-data. A disadvantage of the use of secondary data for 
a longitudinal investigation is that the information concerning the specific 
purpose of the study may be limited. For example. the EPOZ-survey had not 
been designed to measure the amount of bone in the skeleton. From a clinical 
point of view the application of techniques such as Single or Dual Photon 
Absorptiometry might have been preferable over Metacarpal Radiogrammetry. 
However. Metacarpal Radiogrammetry was an acceptable alternative (chapter 3). 
A disadvantage of the choice of the study population from the general 
population was that rare manifestations of osteoporosis had a low frequency in 
the study. For example. the serious kind of vertebral osteoporosis as it may be 
encountered in clinical practice was uncommon in the study population. Only 
three women out of the 855 investigated suffered from progressive collapses of 
multiple vettebrae. Also. the study population was still too young. to study 
fractures of the femoral neck. These fractures may have major consequences 
both for the victim and for medical costs. 8 However. the frequency of these 
fractures is only high among subjects aged 70 years and older. In the Nether-
lands. in 1982 the incidence of femoral neck fractures was 1.3 per 1000 
women-years for women aged 45 to 69 years. and 9. 7 per 1000 women-years for 
women aged 70 years and older.9 
A disadvantage of the choice of the statistical analysis was that it did not 
guard for the presence of chance relationships. As a consequence. caution is 
required in interpreting the relationship between separate risk factors and 
fracture Iisk. 
Finally. the simultaneous use of many variables in a single analysis sets high 
demands to the completeness of the data for each variable. As a result of a 
small percentage of missing values for each variable. mostly because of tech-
nical reasons. the complete data set was considerably reduced. Of I 0 I 4 women 
for whom a fracture history was available. only 742 women had complete data 
for all variables that were used. The introduction of a bias that could have 
resulted from this problem was checked in a comparison between the data-set 
with and without missing values. 
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7.4. Metacarpal bone loss 
In the second analysis the occurrence of bone loss in the study population 
was evaluated. The investigation was especially well fit for this purpose. It was 
the first population based longitudinal study of reasonable size with a long 
period of follow-up. A basic question in osteoporosis research is whether 
differences in the rate of bone loss between individuals really exist (Albright) 
or whether the rate of bone loss is of similar magnitude for all elderly subjects 
(Newton-John). If the first hypothesis comes closest to reality. it might be 
useful to early detect the subgroup of fast bone losers for prevention of 
osteoporosis. If the second hypothesis offers a better description of reality. it 
might be more useful to gear preventive measures towards all subjects or 
towards individuals who have a low bone density to begin with. 
A problem in the evaluation of the presence of differences in the rate of 
bone loss between individuals is that the amount of bone tissue that is lost per 
year is relatively small in comparison to the measurement error. Ordinary bone 
loss in postmenopausal women will proceed at an average rate of approximately 
I per cent per year. The precision of the most precise measurement techniques 
is of the same magnitude. As a consequence. a long period of follow-up is 
required for reliable measurements of bone loss. But even with the nine year 
petiod of follow-up of the present investigation, special precautions were 
required to avoid confusing differences in measurement en-or with actual 
differences in the rate of bone loss. 
In the statistical analysis of differences in the rate of bone loss between 
individuals three different approaches were used. Firstly. similar to Newton-
John. the standard deviations of bone density were compared in different age 
groups and within age groups over the period of follow-up. Secondly. direct 
inferences were made from the bone loss that was actually measured. together 
with an estimation of the measurement error. Thirdly. the shift of individuals 
within the frequency distribution of bone density (horse racing) was evaluated 
in an analysis of the relationship between rate of loss and initial level of bone 
density in consecutive age groups. 
From these analyses it was infen·ed that differences in the rate of bone loss 
between individuals were present. A model was proposed for the pattern of bone 
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loss as it occurs m the general population. This model was based. both on the 
empirical data and on the (biological) assumption that rate of bone loss was 
determined by two factors: I). the magnitude of the disequilibrium between bone 
formation and bone resorption and 2). the size of the metabolic sUiface that is 
present within the bone tissue. The influence of the second. a large metabolic 
sutface. makes that at a younger age. shortly after bone loss has started. the 
rate of bone loss is fastest for individuals with a high bone density. The 
influence of the first. differences in the magnitude of the disequilibrium. makes 
that individuals with a high rate of loss shift clown in the frequency distri-
bution of bone density. resulting in high rate of loss for individuals with a low 
bone density at an older age. The model illustrates the limited validity of a 
description of the homogeneity of a process of change. just on the basis of 
changes in standard deviations. 
The principle of the analysis of horse-racing has been applied previously in 
different research areas such as pulmonary function and hypertension research. 
The approach is new to the field of osteoporosis. A disadvantage of the 
technique may be its statistical complexity. However. we knew of no alternative 
way to extract the same kind of information. Since the analysis has not been 
perlormed previously on the same kind of data. the results can not be compared 
to different populations. 
Next to the question concerning the presence of differences in the rate of 
bone loss between individuals. an attempt was made to evaluate the clinical 
relevance of differences in the rate of bone loss for the occurrence of osteo-
penia. In this analysis, a comparison was made between the prediction of 
osteopenia at follow-up on the basis of initial bone density and on the basis 
fast rate of bone loss. Here. the analysis was kept simple and straightforward. 
The results were expressed in terms of sensitivity and specificity. is clinically 
interpretable measures. Of course. bone density at old age will be most correc-
tly desctibed as a function of initial bone density. rate of bone loss and time. 
However. if a choice has to be made between information bone density or bone 
loss. to predict bone density over a 9 year period. the first would be the more 
inf01mative. The model of equal bone loss for all individuals may not be correct 
in an academic sense. but it may be the more pragmatic view for clinical 
practice. 
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7.5. Endogenous oestrogen activity and osteoporosis 
In the third analysis the relationship between endogenous oestrogen activity 
and osteoporosis was evaluated. This relationship has been studied previously by 
vaiious investigators. However. the present investigation represented the first 
study in which all components of postmenopausal endogenous oestrogen activity: 
oestradiol. oestrone and sex hormone binding globulin (SHBG) could be related 
to the three major constituents of the osteoporotic syndrome: low bone density. 
high rate of bone loss and increased risk of fractures in a multivariate analysis. 
In addition. the independent contribution of the theoretical "precursors" of 
postmenopausal endogenous oestrogen activity: body mass and androstenedione 
concentrations could be included in the analysis. The population had a sufficient 
size to allow the use of a multiple linear regression analysis to evaluate the 
independent relationship of the various components of endogenous oestrogen 
activity in relation to osteoporosis. 
The results suggested that high level of SHBG and perhaps low level of 
oestradiol could be responsible for some of the differences in the rate of bone 
loss between individuals. Since all women were postmenopausal and oestrogen 
levels were in general low. these results may serve as an indication of the 
sensitivity of bone tissue for oestrogen deficiency. 
The study design of this part of the investigation warrants some additional 
discussion. The relationship between oestrogen activity and bone density was 
analyzed cross-sectionally. This approach is similar to the majoiity of other Iisk 
factor studies in this field. For the pa1t of the study of bone loss and fractures 
in relation to endogenous oestrogen activity. the investigation could be charac-
terised as a retrospective cohort study with a backward directionality. Although 
some frozen serum samples from the initial EPOZ-survey were still available. we 
had some doubts whether measurements of a globulin substance such as SHBG 
would be reliable in 10-year old serum. Therefore. the oestrogen activity as was 
measured at follow-up was related to the bone loss and fractures that occurred 
during the previous nine years. The approach may be compared to the usual 
case-control design. An advantage of the present design was that the control 
group may be conceived as being selected exactly from the source population of 
the cases. The approach would give biased result if fractures or bone loss would 
Ill 
have an influence on the endogenous oestrogen levels. or if a third factor 
would influence both vmiables independently. The existence of such biases were 
considered to be unlikely. with the exception of a possibility of some women 
using exogenous oestrogens as a therapy for osteopenia or fractures. Of the 
nine women who reported current use of some kind of postmenopausal substi-
tution therapy (oestrogens. progestagens or androgens) four were excluded from 
the analysis because of premenopausal oestrogen levels above I 00 pmol/1. The 
remaining five had average levels of oestrogens and did not in any way 
influence the results. Although the approach of a retrospective cohort design 
may be somewhat unusual the associations were nevertheless considered to be 
valid. In the judgement that was made concerning the causality of the relation-
ship between endogenous oestrogen activity and osteoporosis. the criterion of 
directionality of cause and effect could not be used. In the present analysis. 
however. the consistency of the association of high concentrations of serum 
SHBG to low bone density. high rate of bone loss and increased risk of 
fractures was striking. Furthermore. the findings were in line with the general 
hypothesis of an etiologic role of oestrogens activity in relation to osteoporosis. 
The results encourage further -preferably prospective- investigations. with 
specific attention for the role of SHBG. 
7.6. Recommendations 
This investigation intended to evaluate the accuracy of fracture prediction based 
on known risk factors of osteoporosis. The reason for the evaluation was a 
suggestion from the literature that strategies for prevention of osteoporosis 
should be directed at subjects who have a high risk of fractures. One approach 
to select these subjects could have been the risk factor status. The results of 
described in chapter four suggest that this approach of fracture prediction is 
inaccurate from a clinical point of view. Furthennore. the results described in 
chapter five suggest that bone loss is present in the majority of postmenopausal 
women. yet. differences in the rate of bone loss were of relatively little 
impOiiance for prediction of osteopenia. As a consequence. it may be doubted 
whether any determinants of bone loss will be useful for prediction of 
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osteopenia related fractures. The results indicate that selection of women for 
fracture prevention programmes. either on the basis of tisk factors or on the 
basis of fast bone loss is most likely to be inefficient. As an alternative 
approach it has been suggested that a high-risk group of women might be 
selected on the basis of bone density measurements around the age of the 
menopause. In the present investigation the efficiency of this approach could 
only be tested for Metacarpal Radiogrammetry. The relationship of metacarpal 
bone density to fracture risk was far too weak to be of any value in this 
respect. However. many different techniques of measuring bone density may be 
applied to various locations in the skeleton and without the empirical data the 
possibility that some technique could be useful for selection of subjects at high 
risk of fractures can· not be excluded. At present no such technique is available. 
Apat1 from age and sex. few factors appear to be useful in guiding the 
allocation of preventive efforts that are aimed at reducing the number of 
fractures in the elderly population. Considering these disappointing results. it 
seems more appealing to direct our efforts towards the total population. or at 
least towards the total group of postmenopausal women. instead of selecting 
specific high risk groups. Several measures of intervention that might be 
advised to the whole population of postmenopausal women have been suggested 
again and again in the literature ever since Albright first drew attention to the 
clinical syndrome of osteoporosis. These measures include advice about sufficient 
consumption of calcium, vitamin D and perhaps fluor, advice about adequate 
physical activity and about the use of postmenopausal oestrogen substitution 
therapy. The latter intervention is the only measure for which the effectiveness 
has been positively demonstrated and accepted in the consensus conferences 
that were previously mentioned (chapter I). The results described in chapter six 
lend further support to the potential beneficial influence of oestrogens on the 
preservation of the skeleton. However. the debate concerning the possible side 
effects of postmenopausal oestrogen substitution therapy still continues. Final 
judgement whether this therapy could be safely advised to the population as a 
general health measure will depend on the outcome of this discussion. 10 
From the previous discussion it seems that the time has come for properly 
designed intervention research. measllling the effect of interventions on both 
the rate of bone loss and the risk of fractures. With the present state of 
113 
knowledge. this kind of research is most likely to be of value if interventions 
to be tested are suitable for application to the total population. or at least to 
the total group of postmenopausal women. 
Next to "preventive" intervention research it seems useful to obtain a better 
understanding of factors that determine the peak bone density. since it appears 
that bone density at old age is strongly determined by bone density at a 
younger age. Perhaps. an effective prevention of osteoporosis should start at an 
age when the skeleton is still growing. 
As a final remark it may be wo1ih considering that. although this thesis dealt 
with low bone density as a supposed cause of fractures. few fractures occur 
without at least a minor accident. Despite the neglect of this factor in 
osteoporosis research. the potential value of accident prevention among the 
elderly should not be underestimated. 
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Chapter 8 
Samenvatting 
Een groep van I 167 vrouwen van middelbare leeftijd werd gedurende een 
periode van negen jaar gevolgd. Nagegaan werd of een kombinatie van risiko-
faktoren voor osteoporose praktisch bruikbaar zou kunnen zijn om een groep 
vrouwen met een verhoogd fraktuur risiko op te sporen. Daarnaast werd het 
optreden van botverlies in een normale populatie bestudeerd en de natuurlijke 
oestrogeen aktiviteit na de menopauze werd in verband gebracht met het 
optreden van botverlies. !age botmassa en frakturen. 
In hoofdstuk twee wordt de historische ontwikkeling van het concept van 
osteoporose beschreven. Er wordt een onderscheid gemaakt tussen het concept 
van osteoporose vanuit een klinisch en vanuit een epidemiologisch gezichtspunt. 
De epiclemiologie van osteoporose worclt besproken. 
De methode van het onderzoek worclt beschreven in hoofdstuk clrie; de 
resultaten worden beschreven in de hoofdstukken vier. vijf en zes. Een bespre-
king van de methode van onclerzoek volgt in hoofdstuk zeven, te samen met 
enige aanbevelingen voor verder onderzoek. 
Fraktuur prediktie (Hoofclstuk 4) 
Tijdens de 9 jaar clurende vervolgperiode traclen 203 frakturen op bij 163 
vrouwen (Tabel II; pagina 57). Dit komt overeen met een gemiddelde incidentie 
van 22.2 frakturen per 1000 vrouw-jaren. De kans op een of meer frakturen 
geclurencle de onderzoeksperiocle was 0.16. Frakturen van de clistale onclerarm en 
van de wervels vormden samen ongeveer de helft van aile frakturen (n =92). 
Deze frakturen worden vaak als typisch beschouwd voor postmenopauzale 
osteoporose (type I osteoporotische frakturen). 
Twaalf risikofaktoren (Tabel I; pagina 54) werclen prospektief in verband 
gebracht met het risiko van alle frakturen of van type I osteoporotische 
frakturen. De gegevens van 742 vrouwen waren volledig voor aile faktoren. Een 
significant verhoogd fraktuur risiko were! gevonden voor hoge leeftijd en laag 
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Relatief Cotticaal Oppervlak. Enige bescherming tegen frakturen werd gevonden 
voor geringe lichaamslengte en geringe (!) breedte van de pols. Geen van de 
tisikofaktoren was sterk gerelateerd aan het risiko van frakturen. De relatie 
tussen risikofaktoren en fraktuurrisiko was niet essentieel verschillend voor de 
groep van aile frakturen of voor de subgroep van type I osteoporotische frak-
turen. 
De voorspellende waarde voor het optreden van frakturen werd nagegaan voor 
een kombinatie van risikofaktoren. De informatie over risikofaktoren werd 
gecombineerd met behulp van een stapsgewijze logistische regressie techniek. 
Voor ieder individu werd zo een Fraktuur Risiko Score (FRS) berekend. die laag 
was voor vrouwen met weinig risikofaktoren en hoog voor vrouwen met vee! 
risikofaktoren. Het risiko van frakturen in quintielen van de FRS wordt weerge-
geven in Figuur IV (pagina 62). De FRS was sterk gerelateerd aan het risiko 
van frakturen. Het relatief risiko van het hoogste ten opzichte van het laagste 
quintiei was 6.4 voor aile frakturen en 7.0 voor type I osteoporotische frak-
turen. Echter. het gebruik van de FRS met het oog op selektie van een groep 
vrouwen voor fraktuur preventie zou onbetrouwbaar zijn. Indien het hoogste 
quintiel van de FRS zou worden beschouwd als een test voor fraktuur voor-
spelling. dan zou de sensitiviteit en specificiteit in het huidige onderzoek 0.38 
en 0,84 bedragen voor de prediktie van aile frakturen en 0.47 en 0.83 voor de 
prediktie van type I osteoporotische frakturen (Tabel Ill; pagina 63). In de 
praktijk zou dit betekenen dat in een selektie van 20 procent van aile vrouwen 
op basis van deze score, minder dan 40 procent van de frakturen zou v66r-
komen. Andersom zou ongeveer 70 procent van geselekteerde vrouwen in de 
claarop volgende negen jaar geen fraktuur krijgen. Deze schatting van sensiti-
viteit en specificiteit zal aan de optimistische kant zijn. omdat de score op een 
zelfde data set werd berekend en getest. Het klinische gebruik van informatie 
over risikofaktoren van osteoporose bij de selektie van vrouwen voor fraktuur-
preventie programma's lijkt niet aan te bevelen. 
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Botverlies (Hoofdstuk 5) 
Handfoto's van 799 vrouwen waren aanwezig voor zowel het initiele als het 
vervolgonderzoek. De verandering van het Relatief Corticaal Oppervlak (bot-
dichtheicl) met de leeftijcl worclt weergegeven in Figuur III (pagina 79). Voor het 
50e jaar. of v66r het optreclen van de menopauze. wercl geen noemenswaarclige 
afname in RCO vastgestelcl. Na het 50e jaar tract een verlies op van ongeveer 
I % van het gemiclclelde niveau per jaar. De frequentievercleling van RCO worclt 
weergegeven in Figuur IV (pagina 81) in 5-jaars Ieeftijcl categorieen. In de 
oudere Ieeftijclsgroepen lag de gehele vercleling van botdichtheicl lager. in 
vergelijking met de jongere Ieeftijclsgroepen. Wanneer een arbitraire grens voor 
!age botdichtheic! (osteopenie) were! gelegd bij 70 mm2%. clan nam de prevalentie 
van osteopenie toe van 5% voor vrouwen tussen 45 en 49 jaar oucl tot 68% voor 
vrouwen van 70 tot 76 jaar oud. 
Uit het longituc!inale gedeelte van het onderzoek bleek dat een verlies in RCO 
was opgetreden bij 95% of meer van de vrouwen die bij aanvang van het 
onderzoek ouder waren clan 50 jaar. Het tempo van botverlies was niet gelijk 
voor ieclereen. Er waren aanwijzingen voor verschillen in het tempo van 
botverlies, die over tangere tijd voortduurden. Op jongere Ieeftijd. kort nadat 
het botverlies was begonnen. was het tempo van botverlies het hoogste bij 
vrouwen met een hoge botdichtheid. Op oudere leeftijd, wanneer het botverlies 
mogelijk a! tangere tijcl bestoncl. was het botverlies het hoogste bij vrouwen met 
een lage botdichtheicl. De bijdrage van een hoog of een laag tempo van bot-
verlies aan het optreclen van osteopenie was echter gering. De individuele 
verschillen in het niveau van botclichtheicl op jongere leeftijd waren van meer 
invloed. Een voorspelling van het optreclen van osteopenie bij het vervolg-
onclerzoek op basis van een hoog botverlies was onnauwkeurig (sensitiviteit: 0.6 I 
en specificiteit: 0.65). Eenzelfcle voorspelling op basis van de botclichtheicl bij 
het eerste onclerzoek was vee! nauwkeuriger (sens.: 0.88 en spec.: 0.79). Blijk-
baar had de botclichtheicl op jongere leeftijcl nog steeds een overheersende 
invloecl op de botclichtheicl op oudere leeftijcl. 
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Endogene oestrogeenaktiviteit en osteoporose (Hoofdstuk 6) 
Bij het vervolg gedeelte van het onclerzoek were! de endogene oestrogeen-
aktiviteit bepaald door het meten van de serum concentratie van oestradioL 
oestron. anclrosteendion en sex hormoon bindend globuline (SHBG). Deze 
faktoren. en ook de Quetelet-index. werden gerelateercl aan het niveau van het 
Relatief Corticaal Oppervlak ten tijcle van het vervolgonderzoek. aan het verlies 
in RCO dat in de voorafgaande periode sinds het EPOZ-onderzoek was opge-
treden en aan het risiko van frakturen gedurende dezelfcle perioc\e. De gegevens 
waren kompleet voor 746 postmenopauzale vrouwen. 
Met uitzonclering van anclrosteendion waren alle parameters als afzonclerlijke 
faktoren significant gerelateerc\ aan botdensiteit en aan botverlies. In een 
multipele lineaire regressie analyse bleek botdensiteit positief gerelateercl aan 
serum oestradiol en aan de Quetelet-inclex en negatief aan serum SHBG (Tabel 
II; pagina 93). Botverlies was negatief gerelateerd aan serum SHBG (Tabel Ill; 
pagina 94). Serum oestron had geen onafhankelijke relatie van enige omvang met 
botdensitiet of botverlies. De relatie tussen de Quetelet-index als afzonderlijke 
factor enerzijds en het botverlies anderzijds werd in de multivariate analyse 
geheel verklaard uit de positieve korrelatie van de Quetelet-inclex met het serum 
oestradiol en de negatieve korrelatie met het serum SHBG. De ongunstige 
invloed van serum SHBG op botdensiteit en botverlies was sterker dan de 
gunstige invloed van serum oestradiol. Waarschijnlijk moet deze werking van 
SHBG worden verklaard door een invloed op het vrije oestradiol en mogelijk ook 
op het vrije testosteron. Beide hormonen worden geinaktiveerd door binding aan 
SHBG. 
Naast de relatie van SHBG met botclensiteit en botverlies bestond er voor 
SHBG ook een relatie met het risiko van frakturen. Voor de groep oudere 
vrouwen. boven de 65 jaar. were! gevonden dat het gemiddelcle niveau van SHBG 
hoger Jag bij vrouwen met een voorgeschiec\enis van type I osteoporotische 
frakturen in vergelijking met vrouwen die geen frakturen hadclen gehacl 
(Tabel IV; pagina 95). 
De resultaten suggereren een invloed van endogene oestrogeen aktiviteit bij 
het ontstaan van postmenopauzale osteoporose. Inaktivering van postmenopauzaal 
endogeen oestradioL en mogelijk ook van testosteron, door binding aan SHBG 
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kan hierbij een rol spelen. Het is mogelijk clat langclurige blootstelling aan een 
hoge serum concentratie van SHBG uiteindelijk bijclraagt tot een verhoogd risiko 
van type I osteoporotische frakturen. 
Konklusies (Hoofclstuk 7) 
I) Frakturen kwamen frequent voor bij vrouwen van miclclelbare leeftijcl en 
het fraktuurrisiko nam toe met cle leeftijd. 
2) Frakturen van de pols en van de wervels (Type I osteoporotische frak-
turen) waren samen met frakturen van de kleine beentjes van hanclen en 
voeten het meest frequent. 
3) Het merencleel van de wervelfrakturen was voorafgaande aan het onderzoek 
niet gecliagnostiseercl. waarschijnlijk cloorclat cleze frakturen vaak asympto-
matisch waren. 
4) Voorspelling van het optreclen van frakturen op basis van risikofaktoren 
van osteoporose was onbetrouwbaar. 
5) Verlies van botweefsel tracl op bij meer clan 95 procent van de vrouwen 
boven de vijftig jaar. 
6) Het tempo van botverlies beclroeg ongeveer I procent van de initiele 
botclichtheicl per jaar. 
7) Het tempo van botverlies was niet gelijk voor aile vrouwen; bij sommigen 
verliep het verlies sneller clan bij ancleren. 
8) dp jongere leeftijcl was het tempo van botverlies het hoogste bij de 
vrouwen met een hoge botclichtheicl; op ouclere leeftijcl was het tempo van 
botverlies het hoogste bij de vrouwen met een !age botdichtheid. 
9) Verschillen in het tempo van botverlies waren van betrekkelijk weinig 
belang voor het optreclen van osteopenie. De initiele botclensiteit had een 
overheersencle invloecl. 
10) Lichaamsmassa (Quetelet-inclex). serum concentratie van oestron. oestradiol 
en sex hormoon binclencl globuline (SHBG) waren allen gerelateercl aan het 
voorkomen van osteoporose; serum anclrosteenclion was clat niet. 
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I I) De relatie tussen lichaamsmassa en osteoporose were\ gecleeltelijk verklaarcl 
door de relatie tussen lichaamsmassa en endogene oestrogeen aktiviteit. 
Een onafhankelijk relatie tussen een !age Iichaamsmassa en een !age 
botclichtheicl bleef onverklaarcl. 
12) De relatie met osteoporose was sterker voor oestradiol clan voor oestron: 
de relatie was het sterkste voor SHBG. 
13) Als onafhankelijke faktor (na standaarclisatie voor de overige faktoren) was 
een hoge serum SHBG concentratie gerelateercl aan een !age botclichtheicl. 
aan een hoog tempo van botverlies en aan een hoog risiko van frakturen. 
Een !age oestradiol concentratie was gerelateerd aan een !age botdichtheid. 
De konklusies hebben betrekking op een normale populatie vrouwen van 
micldelbare Ieeftijd, die verg._elijkbaar is met een populatie die bijvoorbeeld een 
huisarts zou kunnen bezoeken om advies te vragen over preventie van osteo-
porose. Botverlies blijkt op te treden bij praktisch aile vrouwen na de meno-
pauze. onder andere onder invloed van de natuurlijke oestrogeendeficientie. Het 
selekteren van een subgroep van vrouwen voor fraktuur preventie. op basis van 
risikofaktoren van osteoporose. of op basis van een hoog tempo van botverlies 
lijkt niet bijzonder efficient. 
122 
Appendix 
EPOZ Follow-up Questionnaire 
An english translation of the questionnaire that was used for the follow-up 
part of the investigation is reproduced here. The purpose of the questionnaire 
was to collect information concerning the occurrence of fractures and accidents 
during the period between the initial and the follow-up investigation. In 
addition. infmmation was collected concerning factors that were potentially 
related to bone density. bone loss or risk of fractures. This included simple 
information concerning physical activity. medical history. age and circumstances 
of the menopause. use of postmenopausal oestrogen substitution therapy. 
smoking. and consumption of alcohol and coffee. The questions that were 
included as indicators of physical activity were chosen from the initial EPOZ-
questionnaire. with the exception of question 30 (page 132). This question was 
inspired on a publication by Sallis. who suggested that a question like this 
could serve as a rough. but useful estimate of the physical activity. 1 The 
questions concerning joint pain (page 138), were also selected from the initia,l 
EPOZ-questionnaire. These questions were included, because a comparable 
version of the questionnaire was used for a longitudinal investigation of 
progression of osteoarthrosis in a population that was overlapping with the 
population studied in the present investigation.2 
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EEOZ 
(EPIDEMIOLCX;ICAL PREVENTIVE INVESTIGATION ZOEI'ERMEER) 
THIS QUESTIONNAIRE IS B::lUND FOR: 
name 
street 
postal code 
residence 
date of birth 
1. In case that the above mentioned infonnation is incorrect, would you 
please fill in the correct infonnation belCM ? 
name 
street 
postal code 
residence 
date of birth 
2. Please indicate whether the appointment to 
visit the EroZ-centre is convenient Yes D NoD 
Under what phone number can you be reached in case the appointment has to be 
changed? 
Ihone number: ..... - ..•..... 
--------------------------------- ·---
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This questionnaire consists of 16 pages. '!he majority of the questions can 
be answered with a cross in the appropriate box. Please use a pencil, so you 
can make corrections if necessary. If you are unable to answer a question, 
please put a cross in front of the I1lllliJer of the question. 
EXAMPLE'S: 
If you are in the possession of a car put a cross beh:inl "yes" as is 
indicated here: 
1. Are you in the possession of a car ? Yes [KJ No 0 
If you prefer to eat spinach put a cross before spinach as is indicated 
here: 
2. What vegetables do you like best ? 
D cabbage 
[KJ Spinach 
D Courgette 
If you are unable to answer the following question put a cross before the 
question as is indicated here: 
x 3. Have you had mumps ? Yes 0 No 0 
----------- , ____ , 
-----------------------
Some of the questions concern the use of medication. Please bring along to 
the centre all medication you cur.rent.ly use 
, _______________________________ _ 
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'1be follt:NinJ cp:stions coo::e:m fiactm:es of tbe bc:nes airl accidents 
1. Did you fracture any one of your bones in the 
past ten years (after january 1st 1975) ? 
If NO, please continue with question 7. 
2. If YFS, what did you fracture 
Yes D NoD 
3. Could you indicate as accurate as possible when this happened ? 
Please give month and year. 
Month: .......... . Year: 
4. What was the cause of the fracture ? 
(For example: traffic accident, sporting accident, fall from the last 
step of the stair). 
5. What was your opinion of the accident ? 
D The accident was so insignificant, that I was actually surprised I 
had a fracture. 
D The impact of the smash was so strong, that I was not surprised I 
had a fracture. 
6. By whom and where were you treated for this fracture ? 
7. 
D General practitioner Name: 
0 Hospital Name: 
Name doctor: 
Did you have any fractures more then 10 
years ago (before january 1st 1975) ? Yes 0 No 0 
If YFS, how many times did you have a fracture ? . . . . times. 
8. Did you have an accident in the past ten years, for which 
you had to go to your General Practitioner or 
the hospital, without having a fracture ? Yes D No D 
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9. Did you fall in the past year ? Yes D NoD 
10. 
11. 
12. 
If YES, how many times did you fall ? times. 
What was the cause of falling ? (several answers possible) 
D stumbling or slipping 
D dizziness 
D fainting 
D sudden weakness in the legs 
D other (please describe) •.....•••.......•.......... 
Do you have difficulties with walking ? Yes D 
Do you use a stick if you walk outdoors ? Yes D 
Did you have to stay in bed for a period of 
two weeks or more the past 10 years ? Yes 0 
No 
No 
No 
If YES, how long did you have to stay in bed ? ...... weeks. 
Please fill in for what reason and when this had been ? 
13. Do you spent regular time outdoors in smmner ? 
(more than 8 hours per week) Yes D No D 
'1he follow:in:J tpeSticns ccn:::em pain in the back 
1. Have you had attacks of pain in the back lasting 
D 
D 
D 
longer than two weeks in the past 10 years ? Yes D No D 
If NO, please continue on the next page. 
2. If YES, how often did these attacks occur ? 
3. How long did an attack last ? 
4. Did you have to stay in bed because of it ? 
5. Have you been treated for these attacks ? 
If YES, what did the treatment consist of ? 
6. Do you know what caused the pain ? 
times. 
weeks. 
Yes D NoD 
Yes D NoD 
Yes D NoD 
If YES, please describe .........•••.................•.. 
128 
'Jbe follow:i.n] tpeSticms ccnce:r:n your 'Werle and daily activities 
1. IX> you have work (besides your household) ? Yes D No D 
If NO, please continue on the next page. 
2. HCJW' do you got to your work (more than one answer is possible) and how 
Illl.lch time does that take. 
D by foot ........ minutes 
D by public transport ........ minutes 
D by bicycle ........ minutes 
D by autocycle ........ minutes 
D by car or taxi ........ minutes 
3. HCJW' many years do you work in your current profession ? . . . years 
4. What is your current profession ? 
Please give the specific name of your profession or function 
5. HCJW' many hours per day do you work ? 
D 1-4 hours (half days or less) 
D 5-9 hours (half to full days) 
D full days 
D more than 9 hours (more than full days) 
6. HCJW' many days per week do you work ? 
D lor2days? 
D 3or4days? 
D 5 days? 
D 6or7days? 
7. Are you physically active at your work? 
D No, I sit virtually all the time 
D Not very active, some walking andjor lifting 
D Yes, I am on the move all the time during work 
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8. IX> you perfonn your own domestic work ? 
D Yes, I do all my domestic work on my own 
D Yes, and everyone in the house gives a hand 
D Yes, and I have help for ... hours per week 
D No, my domestic work is done by someone else 
If NO, please continue with question 11. 
9. For heM many persons do you keep house ? (Include yourself) 
persons 
10. HCM many hours per day do you spent on domestic worlc ? hours 
11. HCM many hours per day do you cycle ? 
0 None 
D Less than half an hour per day 
D More than half an hour per day 
12. HCM many hours per day do you walk outdoors ? 
D None 
D More than half an hour 
D More than half an hour, but less than an hour 
0 More than an hour per day, namely . . • hour 
13. IX> you climb the stairs daily ? 
If YFS, heM often ? 
- indoors usually ..•• times per day 
- outdoors usually . . . . times per day 
14. IX> you work in the garden sometimes ? 
If YFS, heM many hours per week 
HCM many years do you do this work 
15. Are you a handyman (do you make repairs 
or do naintenance work yourself) 
16. IX> you perfonn sporting, gymnastic or 
jogging activities ? 
If NO, please continue with question 20. 
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Yes 0 No 0 
Yes 0 No 0 
hours 
year 
Yes 0 No 0 
Yes D NoD 
17. What kind of sporting activities do you perfo:nn and for haw 
long ? (i.e. korfball since 1975) 
1 .•....••............•...•••• since 19 ..• 
2. • ••..........•...........•• since 19 ••. 
18. Haw many hours per week do you spent on sporting activities ? 
•... hours 
19. Do you participate in sport competitions ? Yes 0 No 0 
'!he folla.rin] questions ~ yan:- lolOl:'k, hcti>ies, etc. in the past ten 
years 
20. Did you work in the past ten years ? 
(not including your present work) 
If NO, please continue with question 26. 
Yes D NoD 
21. What kind of work did you do for the longest period in the past ten 
years ? (not including your present work) 
22. Haw did you got to your work (more than one answer is possible) and how 
l!Rlch time did that take. 
D by foot ........ 
D by public transport ........ 
D by bicycle ........ 
D by autocycle ........ 
D by car or taxi ........ 
23. Haw many hours per day did you work ? 
D 1-4 hours (half days or less) 
D 5-9 hours (half to full days) 
D full days 
D more than 9 hours (more than full days) 
24. Haw many days per week did you work ? 
D 1 or 2 days? 
D 3 or 4 days? 
D 5 days? 
D 6 or 7 days? 
minutes 
minutes 
minutes 
minutes 
minutes 
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25. Were you physically active at your work? 
D No, I sat virtually all the time 
D Not very active, some waJJcing and/or lifting 
D Yes, I was on the move all the time during work 
26. Did you perfonn sporting, gymnastic or jogging activities in the past 
ten years? 
(Not including current sporting activities) Yes D No D 
If NO, please continue with question 30. 
27. What kind of sporting activities did you perfonn and for how long ? 
(i.e. korfball from 1976 until 1981) 
1. . . • • • • • . • • . • • • • • . • . . . . . . . • • from 19. • • until 19 ... 
2. • • • • • . . . . • • • • • • • • . . . • . • • • • • from 19 • • • until 19 ••• 
28. How many hours per week did you spent on sport activities ? 
.... hours 
29. Did you participate in sport competitions ? Yes D No D 
·--------------------
'!he followin:] questions CXlllOeD1 your activities in the past m:xrt:h 
-----------------·----------
30. How much time did you spent on the following activities on an average 
week-day and on an average weekend-day in the past month ? 
A. Very strenuous activity? 
(digging in the garden, vigorous domestic work, vigorous 
cycling with adverse wind, etc.) 
Week-day (hours per day) 
Weekend-day (hours per day) 
B. Moderately strenuous activity? 
Sporting, 
(light domestic work, light sporting, waJJcing, cycling calmly) 
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Week-day (hours per day) 
Weekend-day (hours per day) 
Have yai had any of the folla.r.ing <li seases or mnditions 
INFECriOUS DISEASES 
1. An infection of a joint Yes D NoD 
If YES, which joint ? ...•.•..............•.•. 
2. An infection of a part of the skeleton Yes D No D 
If YES, which part ? 
3. Tuberculosis of the lungs 
CARDIOVASaJIAR DISEASES 
4. High blcxxl pressure 
5. Chest pain 
6. Heart attack 
7. Cerebral haemorrhage 
8. DJring a walk, do you get pain in the calves 
that recovers after a few minutes rest ? 
OlHER DISEASES 
9. Diabetes Mellitus 
10. Diseases of the thyroid 
11. Infantile paralysis ("polio") 
12. Rachitis 
13. Astbrna 
14. Chronic bronchitis 
15. Diseases of the kidneys 
Yes D NoD 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D NoD 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
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'llle followllxj questions CXllXeDl JilYsician trea:brent. IJOiil arrl in the past 
--------------------------------------------------------
OPERATIONS 
16. Have you ever been operated ? Yes D NoD 
17. If YES, please indicate the kirxi an::i year of operation. 
1 •.......••................ in 19 ... 
2 •••••••••••••••••••••••••• in 19 •.. 
3 •••••••••••••••••••••••••• in 19 ... 
4 •••••••••••••••••••••••••• in 19 ... 
18. Have you been admitted to a hospital 
for a reason other than operation ? 
19. If YES, please indicate what for. 
1 •.......•..•..............• in 19 ... 
2 ••••••••••••••••••••••••••• in 19 ••• 
3 ••••••••••••••••••••••••••• in 19 ... 
4 ••••••••••••••••••••••••••• in 19 ..• 
MEDICATION AND CURRENT TREA'IMENT 
20. Are you at present being treated by your general 
Yes D NoD 
practitioner or by a medical specialist ? Yes D No D 
21. Do you use medication (:J?C!Vrlers, pills, 
potions, capsules, inject.ions,etc) ? 
If YES, please indicate what medication. 
1 .......••.................•.. since 19 ... 
2. • •.•••••••••.•••••••••..•••• since 19 ... 
3. . .••.•.....••••.......••.... since 19 ... 
4 ....•...................••... since 19 ..• 
Yes D NoD 
Please briJg alarg all yarr current nalication to the centre! 
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N<:M, sane questions will follOW" CCII'ICe.D'lin1 drildren, the menst::rual pericrls, 
an:i use of ''the pill" 
------------------· 
1. ]):) have children of your own ? (including-
children from a possible previous marriage). Yes D No 0 
If YES, when were your children borne ? 
1st child 19... 4th child 19... 7th child 19 .. . 
2nd child 19. . . 5th child 19. . . 8th child 19 .. . 
3rd child 19. . • 6th child 19. . • 9th child 19 .. . 
If NO, please continue with question 3. 
2. Did you breast feed one or more of the 
children? Yes D NoD 
If YES, haw long has that been ? 
1st child 4th child 
2nd child 
3rd child 
5th child 
6th child 
7th child 
8th child 
9th child 
3. Has there ever been a longer period (three months 
or more) during which the menstruation ceased an:i 
months 
months 
months 
than came back again, without a pregnancy ? Yes D No D 
If YES, haw long did this period last ? months 
What was the cause of it? ................. . 
4. Did you use "the pill" after january 1st 1975 ? Yes D No D 
If NO, please continue on the next page. 
5. If YES, for what reason did you use "the pill" ? 
(more than one answer is possible). 
D As a contraceptive. 
D To regulate the menstruation. 
D For another reason, namely .....•.••.••........... 
6. Could you indicate as accurately as possible, when since january 1st 
1975 you used "the pill" ? (Please give month an:i year) . 
For example FRCM january 1975 UNI'IL may 1978 
UNI'IL 
Month Year Month Year 
1 .............. . 
2. • •............ 
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'Ihe following questions apply only if the :nenst:rual :periods are still ccming 
7. Do the menstrual periods come regularly ? 
If YES, you can skip question 8. 
8. Have your menstrual periods been regular in 
previous time ? 
Yes D NoD 
Yes D No 0 
If YES, how old were you, when your periods became irregular ? 
•... years old 
'Ihe following questions apply only if the :nenst:rual :periods have ceased 
9. How old were you when your menstrual 
periods ceased altogether ? 
10. Please indicate how your periods carne to an end ? 
0 on its own 
D through medication 
D after stopping "the pill" 
.... years old 
D after an operation of the uterus andjor ovaries 
D other reason (please specify) .................••...... 
'Ihe following questions only apply if you have had an cp:rration of the 
uterus or of the ovaries 
11. Has the uterus been removed ? 
Have the ovaries been removed ? 
Yes D No D Don't know D 
Yes D No D Don't know D 
12. How old were you at the time of the operation ? 
13. Have you been treated with feminine honnone or 
"the pill" after the operation ? 
14. Did you ever have menopausal complaints after 
the operation (for example hot flushes) 
...• years old 
Yes 0 NoD 
Yes D NoD 
If YES, how old were you when you had these complaints ? 
.... years old 
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·-----------------------------------------
The following questions concern the use of feminine honnone other than "the 
pill". These are conunonly used for the treatment of menopausal complaints 
(for example hot flushes) or for irregular or superfluous menstrual 
bleeding. Some names of preparations that are often used for menopausal 
complaints are: Premarin, Synapause, ovestin, Lynoral, Dagynil, Progynova 
and Estrovis. other honnones that are used to regulate the menstrual periods 
are: Prlinolut, ruphaston and Orgarnetril. 
15. Have you ever been treated with feminine 
honnone other than "the pill" ? 
If NO, please continue on the next page. 
16. If YES, how were you treated ? 
(more than one answer is possible) 
D Tablets 
D Internal ointment or cream 
D Injection 
D SUbcutaneous inl:>lant 
D other (please specify) ....•........•••.... 
17. What was the reason for treatment ? 
(more than one answer is possible) 
D Menopausal complaints 
D Irregular or superfluous menstrual bleeding 
D Disease (please specify) ........••••.......• 
D other (please specify) •..•.•.........•••.. 
Yes 0 No 0 
18. Could you indicate as accurate as possible in what period of your 
life you used these honnones ? (Pleas, give month and year). 
For example FRC:M may 1975 UNTIL march 1978 
UNTIL 
Month Year Month Year 
1. . .•.........•. 
2. . ..•••..••.... 
3. • ••..••••.•••• 
19. If you remember the name of the preparation, please write it down 
below? 
20. Did you get these honnones from the general practitioner or from a 
medical specialist ? 
D Gen. Pract. D Specialist 
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'!he follow:in:J questions conc:ern :rheumatic and skeletal diseases 
, ___________ , ______________ _ 
Have you ever had one of the follc:Ming diseases ? 
1. Acute rheumatoid arthritis as a child Yes D No D 
2. Orronic rheumatoid arthritis as a child Yes D No D 
3. Gout Yes D No D 
4. crooked back Yes D No D 
If YES, were you treated for it ? Yes D No D 
5. Different length of the legs Yes D No D 
If YES, were you treated for it ? Yes D No D 
Do you wear special shoes or arch support ? Yes D No D 
6. Other rheumatic or skeletal diseases Yes D No D 
7. Do you cur:r:ently have pain in one of the following joints ? 
left hand 
right hand 
in the lower part of the back 
in the upper part of the back 
left hip 
right hip 
left knee 
right knee 
other joint (please specify) •..••••....... 
8. Do you have pain in the joints at night? 
If YES, in which joints ? 
1. . ......................... . 
2. • ••....................••.. 
3. • .•••..•••••••••••••••.•••• 
4. • ..•.•••••...••....••.....• 
9. If YES, is the pain worse than at daytime ? 
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Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D No D 
Yes D NoD 
'1be follcwinj (JESticns oanoem the SIIIOik:ing of cigarettes and shag 
1. Did you eve:r smoke cigarettes or shag ? Yes D NoD 
If NO, please continue with question 7. 
2. DJ you still smoke currently ? Yes D NoD 
If NO, please continue with question 6. 
3. Ho;v many cigarettes do you smoke on average pe:r day ? . •.. cig.jday 
4. Ho;v long have you smoked this m.nnber of cigarettes ? ..••... years 
5. Ho;v many cigarettes pe:r day did you smoke 10 years ago ? 
6. 
D I smoked more 
D I smoked less 
D I smoked the same number 
If you stopped smoking, ho;v long ago was that ? 
---------------------
'1be follcwinj questicns cx::o::e:rn the use of alcdJol and coffee 
----------------------
7. Have you eve:r used alcoholic beverages ? 
If NO, please continue on the next page. 
8. If YFS, do you still drink alcoholic beverages 
occasionally ? 
If NO, please continue with question 12. 
Yes D NoD 
Yes D NoD 
9. Ho;v many glasses of light alcoholic drinks (beer, wine, sherry, etc.) 
do you use on average pe:r day? 
pe:r week? 
pe:r months ? 
glasses 
glasses 
glasses 
10. Ho;v many glasses of strong alcoholic drinks ( geneve:r, vieux, etc. ) 
do you use on average pe:r day ? glasses 
pe:r week ? glasses 
pe:r months ? glasses 
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11. IX> you drink coffee regularly ? Yes D No 0 
If NO, please continue with the next section. 
12. HeM many cups of coffee do you usually drink per day? 
cups 
13. HeM lo!'B do you drink this number of cups of coffee ? 
.... years 
14. HeM many cups of coffee did you use before that ? 
D less 
D same 
D IllOre 
Finally, -we have SCIIe general questioos 
1. IX> you currently have a pension ? Yes D NoD 
If YES, since 19 ••• 
2. Are you medically declared unable to work ? Yes D NoD 
If YES, since 19 ••• 
What is the reason for this ? 
3. If you work nc::M, or have a pension, were you ever 
medically declared unable to work in the past? Yes D No D 
If YES, from 19 ••• until 19 ••• , because of ...•.••..•••..•.... 
4. Please fill in the name of your general practitioner ? 
5. Did you find it difficult to complete this 
questionnaire ? Yes D NoD 
·----------------------
Below ym can :iirlicate 'What ymr cpinian is abart: the questionnaire or you 
can give additialal CCIIIleilt. 
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Epiloog 
Een onderzoek zoals beschreven in dit proefschrift kan slechts tot stand 
komen dankzij de bereidwillige samenwerking met velen. Op deze plaats wil ik 
mijn erkentelijkheid betuigen aan een ieder die op enigerlei wijze heeft 
bijgedragen aan de voltooiing van dit werk. 
Het onderzoek kon slechts worden uitgevoerd dankzij aile inspanningen die in 
het verleden door Professor Dr. Hans A. Valkenburg en zijn medewerkers zijn 
geleverd bij de tot stand koming van het EPOZ-onderzoek. De medewerking van 
de respondenten van het initiele onderzoek en van de 1014 vrouwen die bereid 
waren hun medewerking bij het vervolg onderzoek opnieuw te verlenen vormde 
de ruggegraat van het onderzoek. 
Professor Dr. Jan P. Vandenbroucke was de geestelijk vader van het onder-
zoek zoals het hier is beschreven. Uit zijn kreativiteit werd het plan voor het 
onderzoek geboren en dankzij zijn voortdurende begeleiding kon het projekt 
uiteindelijk voltooid worden. Professor Dr. Hans A. Valkenburg was de gerouti-
neerde epidemioloog. die steeds bij praktische en bij theoretische problemen zijn 
verhelderend Iicht deed schijnen. Zijn bank heeft ook voor mij de funktie 
gehad die binnen het Instituut Epidemiologie vermaard is. De analytische geest 
van Professor Dr. Albert Hofman vormde de drijvende kracht achter de tot 
stand koming van hoofdstuk vijf. 
Professor Dr. Jan C. Birkenhager en mevrouw Dorie H. Birkenhager-Frenkel 
initieerden mij in de wereld van de osteoporose. Als mijn kennis van osteo-
porose is gegroeid boven een rudimentair niveau dan is dat hieraan te danken. 
De voortdurende stimulans van professor Birkenhager heeft belangrijk bijge-
dragen aan inhoudelijke aspecten van het onderzoek. 
Op het gebied van de rontgenologie heb ik veel te danken aan de vruchtbare 
samenwerking met Dr. Willem Th. Trouerbach en zijn medewerkers Andries 
W. Zwambom. Wiebeke J. van Leeuwen en Ma1jolein J. van Kints. 
Bij een epidemiologisch onderzoek van enige omvang vergen de uitvoering van 
het veldwerk en de verwerking van de gegevens steeds de grootste inspanning. 
Deze werkzaamheden werden met bewonderenswaardige werkkracht uitgevoerd 
door de medewetkers van het Instituut Epidemiologie. Het veldwerk werd 
verricht door Helen de Bruijn. Marijke ter Haar. Ria Rijneveldshoek en 
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Carlie Valkenburg. Het leeuwedeel van het administratieve werk werd verricht 
door Hanny Leezer en Joke Burger. 
Vele laboratmium medewerkers in en buiten het Instituut Epidemiologie 
hebben bijgedragen aan de biochemische bepalingen. Binnen het lnstituut wil ik 
met name Ton de Bruijn en Jeanette Drop danken voor de plezierige samenwer-
king. ook in niet-biochemische zaken. Buiten het Instituut waren het met name 
Dr. Frank H. de Jong. Dr. Will H.L. Hackeng. Dr. Huib A.P. Pols en Dr. Be11 G. 
Blijenberg die de bepalingen mogelijk hebben gemaakt. 
Een komputer is een machine die vele complexe werkzaamheden snel en 
efficient kan uitvoeren. Helaas is het apparaat zeer kieskeurig bij het aannemen 
van opdrachten. Een enkel verkeerd woord maakt dat de machine zijn medewer-
king weigert. Naast hun andere verdiensten. is het te danken aan de begeleiding 
van Bram van Laar. Leo Muller. Ton Evers en Dick Tensen dat mijn kommuni-
katie met de PDP. de VAX en de PC niet is uitgemond in een weigering van 
deze apparaten om hun diensten te verlenen. 
Het Instituut epidemiologie en haar karakteristieke mogelijkheden voor een 
vrij wetenschappelijk discourse vormde de stimulerende werkomgeving waar-
binnen het onderzoek kon gedijen. De persoon van mevrouw Cilia Kuynders 
staat voor mij symbool voor de warme gastvrijheid van het Instituut. Met Jan 
van Saase heb ik gedurende twee jaar een kamer. een lichtkast. het EPOZ-
centrum en vele praktische werkzaamheden gedeeld. De gesprekken die wij 
voerden over de wetenschapsfilosofische status van medische kennis en over de 
praktische gang van zaken in de gezondheidszorg vormden voor mij een 
onmisbare achtergrond bij de uitvoering van het onderzoek. 
Bij het schrijven van een proefschrift bestaan er vaak tegengestelde belangen. 
Het is een van de verdiensten van mijn gezin. Hanneke en Steven. dat zij niet 
alleen bereid waren om met regelmaat van hun belangen af te zien. maar daarbij 
ook steeds hun ondersteuning bleven bieden. 
Toen ik in janua1i 1985 begon aan het onderzoek dat hier is beschreven. was 
mijn kennis van de epidemiologie en haar methoden niet grater dan die van de 
gemiddelcle co-assistent. Als ik in de loop van de vier jaar waarin het proef-
schrift tot stand is gekomen iets heb bijgeleerd. dan is dit de verdienste van 
velen: ook van diegenen die hier niet bij name zijn genoemd. De tekm1komingen 
van het werk zoals het nu is voltooid komen geheel voor mijn rekening. 
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